Next Article in Journal
Head-to-Head Comparison of SSTR Antagonist [68Ga]Ga-DATA5m-LM4 with SSTR Agonist [68Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
Next Article in Special Issue
Corema album Berry Juice as a Protective Agent Against Neurodegeneration
Previous Article in Journal
Solidagenone from Solidago chilensis Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway
Previous Article in Special Issue
Modulation of Gut Microbiome Community Mitigates Multiple Sclerosis in a Mouse Model: The Promising Role of Palmaria palmata Alga as a Prebiotic
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Potential Therapeutic Properties of Olea europaea Leaves from Selected Cultivars Based on Their Mineral and Organic Profiles

1
ICBAS, Laboratory of Applied Physiology, School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal
2
CBScin, Centre of Biosciences in Integrative Health, 4250-105 Porto, Portugal
3
Insight: Piaget Research Center for Ecological Human Development, Instituto Piaget—ISEIT, Estrada do Alto Gaio, 3515-776 Lordosa Viseu, Portugal
4
REQUIMTE/LAQV, ISEP, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 431, 4249-015 Porto, Portugal
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2024, 17(3), 274; https://doi.org/10.3390/ph17030274
Submission received: 11 December 2023 / Revised: 10 February 2024 / Accepted: 13 February 2024 / Published: 22 February 2024

Abstract

:
Olive leaves are consumed as an extract or as a whole herbal powder with several potential therapeutic benefits attributed to polyphenols, tocopherol’s isomers, and flavonoids, among others. This study assessed the potential variance in the functional features presented by olive leaves from three different Portuguese cultivars—Cobrançosa, Madural, and Verdeal—randomly mix-cultivated in the geographical area of Vale de Salgueiros. Inorganic analysis determined their mineral profiles while an organic analysis measured their total phenolic and flavonoid content, and scanned their phenolic and tocopherol and fatty acid composition. The extracts’ biological activity was tested by determining their antimicrobial and antioxidant power as well as their ability to inhibit acetylcholinesterase, butyrylcholinesterase, MAO-A/B, and angiotensin-I-converting enzyme. The inorganic profiles showed them to be an inexpensive source able to address different mineral deficiencies. All cultivars appear to have potential for use as possible antioxidants and future alternative antibiotics against some multidrug-resistant microorganisms, with caution regarding the arsenic content in the Verdeal cultivar. Madural’s extract displayed properties to be considered a natural multitarget treatment for Alzheimer’s and Parkinson’s diseases, depression, and cardiometabolic and dual activity for blood pressure modulation. This work indicates that randomly cultivating different cultivars significantly modifies the leaves’ composition while keeping their multifaceted therapeutic value.

1. Introduction

Olea europaea L. is a small tree of the family Oleaceae, typical in tropical and warm temperate regions. This tree is well known for its olives and occupies a prominent position in the Mediterranean commerce as a prime source of olive oil [1]. The olive tree is native to the Middle East and to the coastal areas of the eastern Mediterranean Basin, being distributed also in western Asia and northern Africa. Although olives are now cultivated in several parts of the world, the Mediterranean region still functions as the major contributor, accounting for about 98% of the world’s olive cultivation [2]. According to archaeological records, olives were commercially explored by the Minoans in Crete as far back as 3000 BC [3]. Ancient Greek literature reveals the use of olive oil for body health and the olive tree has a long history of medicinal and nutritional value. Economically, olives appear as an important good as they yield a nourishing edible oil with potential medicinal functions [4]. The rising awareness about the valuable effects of prime nutrition, including functional foods, the pursuit for olives, and their subproducts, has notably increased in high-income countries with rapid expansion of olive-based products [5,6]. Olive oil is the main dietary fat in the Mediterranean diet, associated with a reduced incidence of cardiovascular diseases and some types of cancers [7,8,9,10]. The beneficial effects of olive oil are mainly attributed to its high content of monounsaturated fatty acids (MUFAs) and multifunctional bioactives including tocopherols, carotenoids, and phenolics [11,12]. In addition, such compounds as oleuropein give the unique flavor and taste of olive oil. The content of these components in olives and olive leaves change according to several factors such as type of cultivar, ripeness, harvesting procedure, and agroclimatic circumstances, as well as the processing methods [13,14]. Through history, olive leaf extracts have attended many uses, from tissue conservation in Ancient Egypt to promoting health as a tonic to treat fever and some tropical diseases such as malaria in the Middle East and Mediterranean Basin [15]. Lately, olive leaves have become part of many diets in the form of an extract or as a whole herbal powder [16,17,18]. Olive leaves’ biological compounds yield cardiovascular-protective properties [19]. Not only do numerous studies confirm that olive leaves are able to decline blood pressure, improve blood flow in the coronary arteries [20,21], regulate arrhythmia, and prevent intestinal smooth muscle spasms [22], but their antimicrobial potential against bacteria, fungi, and mycoplasma has also been highlighted [23,24,25,26,27]. Like olive oil, the therapeutic benefits of O. europaea L. folium have been credited to low-molecular-weight polyphenols such as oleuropein (up to 60–90 mg/g dry leaf weight), hydroxytyrosol, tyrosol, and vitamin E isomers of tocopherol, elenolic acid derivatives, caffeic acid, p-coumaric acid, and vanillic acid, as well as flavonoids—luteolin, diosmetin, rutin, luteolin-7-glucoside, apigenin-7-glucoside, and diosmetin-7-glucoside [28,29]. The relevance of the whole olive leaf and its extract has been quickly rising in both pharmaceutical and food industries, not only as a functional food but also as a material used in food additives for preservation [30,31]. The main objective of the present work is to verify if randomly mix-cultivating distinct varieties of this plant induces changes in the nutritional, biochemical, and functional leaf features compared to separated cultivation of the selected Portuguese cultivars, and if so, to provide further information about the influence of the type of cultivation and geographic position on the composition of high-value bioactives and its impact on their therapeutic properties.

2. Results

2.1. Mineral Analysis of the Selected Cultivars

A mineral analysis of aqueous extracts of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal was made by screening the presence of 18 elements through inductively coupled plasma mass spectroscopy (ICP-MS). It was determined that O. europaea Cobrançosa’s mineral content follows a waning predominance of Ca (11 ± 0.05 g/Kg), K, S, P, Mg, Na, Fe, Sr, and Mn (47 ± 0.05 mg/kg) (Table 1). O. europaea Madural’s leaves were found to have a predominance in the decreasing order of Ca (12 ± 0.05 g/Kg), K, Mg, P, S, Na, Sr, Fe, Mn, and Zn (17 ± 0.05 mg/kg) (Table 1). Finally, O. europaea Verdeal’s leaves displayed a waning order predominance as follows: K (13 g/Kg), Ca, P=S, Mg, Na, Sr, Fe, Mn, Zn (17 ± 0.05 mg/kg) (Table 1). According to Table 1, the major mineral components present in these cultivars are calcium (Ca), potassium (K), phosphorus (P), sulfur (S), and sodium (Na); Ca occupies the higher ranking for O. europaea Cobrançosa and Verdeal, whereas K comes first in O. europaea Madural. The third and fourth most-prominent positions vary between S and P in O. europaea Cobrançosa and Verdeal compared to Mg and P in O. europaea Madural. The fifth position is occupied by Mg in O. europaea Cobrançosa and Verdeal, while in O. europaea Madural, it is occupied by S. O. europaea Verdeal leaves also showed a double content of As (7 ± 0.03 mg/kg) (Table 1) compared to O. europaea Cobrançosa and Madural (<3.0 ± 0.03 mg/kg) (Table 1). Overall, the mineral composition for O. europaea Cobrançosa cultivar is more similar to O. europaea Verdeal than to O. europaea Madural.

2.2. Organic Analysis

2.2.1. Nutritional Assessment of OLEs from Selected Cultivars

The water content of the leaves of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal was determined from aqueous extracts through infrared hygrometry readings. The proximate compositions of the three varieties of samples were verified according to AOAC (2000, 2005, 2006) methods [32,33,34,35], drying the milled leaves at 105 °C to constant weight. Ash weight was determined via incineration at 500 °C. Total protein quantification was measured using the Kjeldahl method, while the total lipids were quantified according to Folch et al., 1957 and using Folch solution. The nutritional assessment of both the O. europaea Cobrançosa and Madural cultivars showed a predominance of carbohydrate > protein > lipid > ash. As for the O. europaea Verdeal leaves, the predominance was as follows: carbohydrate > lipid > ash > protein. TFC showed a higher presence among the cultivars in the following order: O. europaea Verdeal > O. europaea Cobrançosa > O. europaea Madural. The higher nutritional content in all of the cultivars was water (within the moisture parameter), whose analysis displayed very close results between the three olive leaf extracts (OLEs), with a very-slightly higher value for O. europaea Madural. The protein content showed similar results for O. europaea Cobrançosa and Madural, while in the O. europaea Verdeal leaves, this value falls to approximately half, about 3.81 ± 0.02% (Table 2). The lipidic composition was higher for the O. europaea Cobrançosa leaf extract, followed by the O. europaea Verdeal and Madural leaf extracts, with this content being very similar between them. Very much alike to the lipidic element, the results for the ash content showed similar values for all of the cultivars, with a slightly higher value for O. europaea Verdeal.

2.2.2. Phenolic Composition of OLEs from Selected Cultivars

The phenolic content of hydroethanolic extracts of the leaves from O. europaea Cobrançosa, O. europaea Verdeal, and O. europaea Madural was measured via a colorimetric assay based on Folin–Ciocalteu reagent. It showed a relative higher presence in the following order: O. europaea Madural > O. europaea Verdeal> O. europaea Cobrançosa. The phenolic profile was also studied with HPLC-DAD. The leaves of O. europaea Cobrançosa displayed a phenolic differential composition following a waning order of hydroxytyrosol > apigenin derivative > apigenin-7-O-glucoside > luteolin-7-O-glucoside > verbascoside. The leaves of the O. europaea Madural cultivar also show a phenolic composition very close to O. europaea Cobrançosa, switching only the third position for apigenin-7-O-glucoside and the fourth position to apigenin-7-O-glucoside. The leaves of the O. europaea Verdeal cultivar showed a slight distinct phenolic arrangement compared to both the previous cultivars, with hydroxytyrosol standing as the major compound followed by apigenin derivative > luteolin-7-O-glucoside > verbascoside > apigenin-7-O-glucoside. Both O. europaea Madural’s and Verdeal’s extracts displayed a higher content of HT: 10.86 ± 0.88 and 10.64 ± 0.15 mg/g dried extract, respectively (Table 3), accounting for 38.76% and 46.12% of the whole phenolic composition, respectively (Table 3)For all three studied cultivars, the least-present phenolic compounds were both caffeic acid and tyrosol.

2.2.3. Fatty Acid Composition of the OLEs of Selected Cultivars

The assessment of the whole fatty acid content of the hydroethanolic extracts from O. europaea Cobrançosa, O. europaea Verdeal, and O. europaea Madural, through gas chromatography analyses, showed overall similar total compositions amongst the three cultivars. Profiling the relative FA content, the results show Σ saturated fatty acids (SFAs) > Σ monounsaturated fatty acids (MUFAs) > Σ polyunsaturated fatty acids (PUFAs) at percentages of 48.6%, 39.9%, and 11.5% for O. europaea Cobrançosa; 46.71%, 37.87%, and 15.42% for O. europaea Madural; and finally 45.75%, 39.74%, and 14.51% for O. europaea Verdeal, respectively (Table 4). The analysis of saturated fatty acids showed a relative higher composition for all three cultivars as follows: palmitic acid (C16:0) > stearic acid (C18:0) > lignoceric acid (C24:0), from which stearic acid was about 25% of the palmitic acid value for all cultivars; lignoreric acid was about 6% of palmitic acid for O. europaea Cobrançosa cultivar, whereas it was 10% for both O. europaea Madural and Verdeal. The most prominent MUFA for all cultivars was oleic acid (OA) (C18:1n-9c) > cis-11-eicoisanoic acid (C20:1n-9)—the latter accounted for about 50% of OA for O. europaea Cobrançosa; around 81% for O. europaea Verdeal; and around 88% for O. europaea Madural (Table 4). Regarding PUFAs, the total amount of omega-6 fatty acids (FAs) appeared to be higher above the total number of omega-3 FAs regardless of the cultivar. The results of the PUFA profiling were alike for all samples, as follows: linoleic acid (LO) (C18:2 n-6c) > gamma linolenic acid (γ-LA) (C18:3 n-6) > dihomo-γ–linolenic acid (C20:3 n-6). The values found for dihomo-γ–linolenic acid were close to 30% of those found for LO, whereas the values of γ-LA were about 50% of LO, for all of the studied cultivars (Table 4).

2.2.4. Antioxidant Activity of the OLEs from Selected Cultivars

The antioxidant activity of hydroethanolic extracts from O. europaea Cobrançosa, Verdeal, and Madural was first determined spectrophotometrically at 517 nm; secondly, the FRAP method measured the reduction of the complex Fe3 + -TPTZ read at 593 nm. Lastly, the anti-NO scavenging power was determined according to the method described in Soares et al., 2021, at 560 nm [36]. The tested extracts showed similar antioxidant behavior against both 2,2-difenil-1-picril-hidrazil (DPPH) and ferric ion (Fe3+)-ligand complexes. Their reducing power followed a waning order of O. europaea Madural > Verdeal > Cobrançosa. The DPPH radical scavenging activity exhibited by the O. europaea Madural and Verdeal extracts was better than their ferric reducing power: 19.9 ± 2.5 and 19.6 ± 2.4 mgTE/g sample, respectively (internal data). The least-powerful antioxidant extract was O. europaea Cobrançosa: 16.6 ± 0.5 mg AAE/g sample against FRAP and 13.6 ± 1.9 mgTE/g sample against DPPH (internal data). Overall, regarding the scavenging activity of each OLE, the IC50 by NO was attained for concentrations above 2000 µg/mL extract (Figure 1 and Table 5).

2.2.5. Antimicrobial Activity of Selected Cultivars

The antimicrobial activity exhibited by diluted hydroethanolic leaf extracts from O. europaea Cobrançosa, O. europaea Verdeal, and O. europaea Madural was tested through agar diffusion assays against the following Gram-positive bacterial strains: Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis (NCTC 11047), and Bacillus cereus (ATCC 14579); and the following Gram-negative strains: Pseudomonas aeruginosa (ATCC 10145), Salmonella Enteritidis (ATCC 13076), and Escherichia coli (NCTC 9001), following an adapted protocol from the guidelines of the Clinical and Laboratory Standards Institute (CLSI).
Diluted extracts showed an overall superior efficacy against the tested Gram(−) strains compared to Gram(+), with the best results being those of the O. europaea Madural and Verdeal extracts against the Gram(−) P. aeruginosa (ATCC 10145) and the Gram(+) B. cereus (ATCC 14579). Despite the O. europaea Madural and Verdeal extracts’ broader antimicrobial activity against Gram(−) strains, the inhibition diameter of the Gram(+) B. cereus (ATCC 14579) was the most-important overall finding for both cultivars: 10.67 ± 0.61 mm and 11.30 ± 0.70 mm, respectively (Table 6), representing about 172.6% and 163.0% of the positive control’s inhibition. On the other hand, O. europaea Cobrançosa’s extract achieved higher efficacy against Gram(−) S. Enteritis, with a relative inhibition of 163.96% compared to the positive control. Regarding Gram(+) strains, the cultivar that showed a wider antimicrobial activity was O. europaea Verdeal, followed by O. europaea Cobrançosa and Madural. Only the leaves of O. europaea Verdeal showed activity against both S. aureus (ATCC 25923) and B. cereus (ATCC 14579), with a result of about 126.74% compared to the positive control. No selected cultivar displayed antimicrobial activity against either Gram(+) S. epidermidis (NCTC 11047) or Gram(−) E. coli (NCTC 9001). Overall, the results showed a higher antimicrobial efficacy of O. europaea Verdeal against B. cereus (ATCC 14579) > P. aeruginosa (ATCC 10145) > S. aureus (ATCC 25923), with inhibition zones of about 11.30 ± 0.70, 11.83 ± 1.01, and 12.38 ± 0.60 mm, respectively (Table 6). The extract of O. europaea Madural functioned better against B. cereus (ATCC 14579) > P. aeruginosa (ATCC 10145) > Salmonella Enteritidis (ATCC 13076), with inhibition zones of about 10.67 ± 0.61 mm, 11.44 ± 0.94 mm, and 13.54 ± 0.10 mm, respectively (Table 6). O. europaea Cobrançosa’s extract acted superiorly against Salmonella Enteritidis (ATCC 13076) > P. aeruginosa (ATCC 10145) > B. cereus (ATCC 14579), with the inhibition zones being about 11.57 ± 0.80 mm, 13.04 ± 0.53 mm, and 13.16 ± 3.97 mm, respectively (Table 6).

2.2.6. Vitamin E Profile of Selected Cultivars

The vitamin E profiles were determined through HPLC-FLD analysis of the hydroethanolic extracts from O. europaea Cobrançosa, O. europaea Verdeal, and O. europaea Madural. Very-low limits of detection (LOD) values were found for all tocopherols (α-tocopherol, δ-tocopherol, γ- and β-tocopherols (Figure 2)). So, no significant biological action could be attributed to E vitamers.

2.2.7. Enzymatic Inhibition by Selected Cultivars

Acetylcholinesterase and Butyrylcholinesterase Inhibition

The inhibition of the acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes by the hydroethanolic extracts was measured according to a modified Ellman method [37]. These results showed an overall higher inhibition of AChE compared to BuChE in the following order: O. europaea Madural > O. europaea Cobrançosa > O. europaea Verdeal, with IC50 values for AChE attained at 376.3 µg/mL, 995.5 µg/mL, and 1057.9 µg/mL, respectively (Figure 3 and Table 7).

Enzymatic Inhibition of Monoamine Oxidases A and B

The inhibition of monoamine oxidases A (MAO-A) and B (MAO-B) by hydroethanolic extracts from O. europaea Cobrançosa, O. europaea Verdeal, and O. europaea was assessed based on the production of 4-hydroxyquinoline from kynuramine deamination, according to Soares et al., 2021 [37]. The results showed an overall higher inhibition of MAO-A enzymatic action by O. europaea Madural > Cobrançosa > Verdeal, with IC50 values registered at 194.1 µg/mL, 251.1 µg/mL, and 294.4 µg/mL, respectively (Figure 4 and Table 8).

Angiotensin-I-Converting Enzyme and Renin Inhibition

Assessments of the inhibition of the angiotensin-I-converting enzyme (ACE) and renin by hydroethanolic extracts of O. europaea Cobrançosa, O. europaea Verdeal, and O. europaea Madural were performed with an ACE activity kit and renin assay kit, respectively, according to the manufacturer’s instructions. The results displayed an overall higher inhibition of renin for all O. europaea extracts. ACE inhibition followed an increasing power in the order of O. europaea Cobrançosa < O. europaea Madural < O. europaea Verdeal; IC50 values for ACE were reached at concentrations of 712.5 µg/mL, 553.2 µg/mL, and 442.4 µg/mL, respectively (Table 9 and Figure 5). On the other hand, the inhibitory power of the renin activity showed an increasing order as follows: O. europaea Madural < Verdeal < Cobrançosa—here, the IC50 readings didn’t allow a value discrimination for extract concentrations. Overall, the concentrations for inhibitory action against renin were all under 125 µg/mL (Figure 5 and Table 9).

3. Discussion

In the present study, the authors used leaf samples of cultivars that pose great importance for the economy of olive oil in Portugal. O. europaea Madural is one of the rarest olive varieties, mostly used for DOP (Protected Designation of Origin) olive oil. O. europaea Madural is known for generating a high yield of olive oil (22%), rich in linoleic acid, with organoleptic sensations varying from those of fresh herbs, apples, and nuts to comprise a lightly bitter and spicy taste [38]. This cultivar holds well in severe climates with a wide temperature range as well as in rough soils. O. europaea Cobrançosa originates from Alto Douro, Trás-os-Montes, next to the Spanish border. O. europaea Cobrançosa trees maintain a regular and large production, delivering an olive oil rich in polyphenols that offers a heightened resistance to oxidation and a balanced taste [38]. O. europaea Verdeal is a well-spread variety in Portugal due to its ability to adapt not only to the very-cold Trás-os-Montes but also to the very-hot Alentejo. Similarly to O. europaea Cobrançosa, the Verdeal cultivar yields large and regular olive harvests that account for a hefty portion of olive oil manufacture, holding particular features such as a thin texture, a persistent and marked fruity scent, and a quite bitter, spicy taste [38].

3.1. Mineral Analysis of the Selected Cultivars

The overall results determined that the major mineral components present in the selected cultivars were calcium (Ca), potassium (K), phosphorus (P), sulfur (S), and sodium (Na); Ca occupied the higher ranking for O. europaea Cobrançosa and Verdeal’s leaf extracts, whereas K came first in O. europaea Madural. These data are coherent with our previous study on O. europaea leaf extracts from an olive grove in another geographical area under different cultivation conditions [39]. Essentially, the inorganic analysis showed a composition in kg of leaves close to or above the daily recommended intake (DRI) values for the following components: Ca, Cr (except for the O. europaea Madural leaf extracts), Cu, Fe, K, Mg, Mn, Sr, Zn, and P, of which the Zn contents are also line with the last study [39]. Amidst metals currently considered essential for normal biofunctioning, our results identified Na, K, Mg, and Ca and block transition metal elements Mn, Fe, and Cu [29]. Chronic low body calcium levels in osteoporosis are usually counteracted through a balanced diet and calcium supplements, often associated with vitamin D and/or Mg [39]. A rich intake of Ca, vitamin D, and protein calls for higher levels of Mg, as well as hypomagnesemia, which may result in hypocalcemia and hypokalemia [40,41,42,43]. Malnutrition, obesity, and alcohol withdrawal might involve inorganic phosphate (Pi) or adenosine triphosphate (ATP) deficiencies, linked to bone diseases and myopathies, as well as the central and peripheral nervous system, for which the treatment requires a proper regulation of phosphorus. Manganese is implicated in several biological processes, with the literature describing manganese deficiencies as uncommon but holding a concern for the association of cancer susceptibility with low Mn-dependent superoxide dismutase activity. A vegetarian lifestyle prevents Mn deficiency though it might lead to iron deficiency [44], which in turn may lead to anemia, and copper build-up in the duodenal epithelium and liver [45]. Copper is predominantly found in the human brain, being absorbed in the intestine and excreted through bile [46]; moreover, it has been identified as a potential therapeutic target for obesity and nonalcoholic fatty liver disease (NAFLD), Alzheimer’s disease (AD), and Parkinson’s disease (PD), among others [39]. On the other hand, our results identified a particularly high value of As in the Verdeal extract of O. europaea, at 7 ± 0.03 mg/kg, which is concerning for the associated toxic effects. The latter’s inorganic study identified an As value of <0.25 mg/kg, much more inferior, probably due to differences already described before [39]. Several strategies for As removal from soil should be considered to avoid the intake of this element by the olive tree [47].The inorganic analysis in this work concedes us to propose OLE from selected cultivars as a practical and inexpensive source of mineral substrates to address the aforementioned disorders related to essential elements such as Ca, K, Mg, Mn, Fe, and Cu deficiencies. In particular, this study suggests O. europaea Madural’s OLE as a potential substrate candidate to address hypocalcemia and hypomagnesemia; O. europaea Verdeal’s leaf extract for hypokalemia and Mn deficiency, taking account the priority of removing As; and lastly, O. europaea Cobrançosa’s OLE to address hypocupremia and sideropenia.

3.2. Organic Assessment

3.2.1. Nutritional Analysis and Fatty Acid Composition of the Selected Cultivars

Despite most of the samples showing a predominance of polyssacharide > protein > lipid > ash, the O. europaea Verdeal cultivar presented differently: polyssacharide > lipid > ash > protein. The lesser the water content, the higher the concentration of phenolic compounds becomes, and the more powerful the antioxidant activity is [48]; thus, in this work, O. europaea Verdeal’s leaves, with their slightly lower humidity values of 8.20 ± 0.35% (Table 2), could be the most useful substrate for retaining a higher-quality phenolic composition. Even so, this value is slightly lower compared to the minor water content values of 8.61 ± 0.12% and 8.43 ± 0.1% previously identified in the leaves of O. europaea Verdeal’s and Cobrançosa’s leaf sprouts [29]. The highest protein content was identified in O. europaea Madural’s leaves, at 6.43 ± 0.09% (Table 2), still comparatively lower than values from our previous study: 7.44 ± 0.02% in O. europaea Madural and 8.85 ± 0.20% in O. europaea Verdeal’s leaves [29]. The highest value of total fat content was shown by the O. europaea Cobrançosa leaves, at 5.03 ± 0.04% (Table 2). Despite the leaves from the remnant cultivars displaying a lesser amount of total lipidic content, being 4.80 ± 0.50% for O. europaea Verdeal and 4.50 ± 0.30% for O. europaea Madural, respectively (Table 2), these are still greater than the amount of total fat found in any sample of the previous study, where the upper value stands out at 4.01 ± 0.14% in the O. europaea Verdeal cultivar [29]. This might relate to differences between the cultivation methods, climate patterns, and soil composition concerning the two distinct harvest locations. Firstly, in Mirandela’s olive grove, the different cultivars were not planted separately by variety, as happened in the olive grove in Valpaços (previous study)—mix cultivation might favor wind cross-pollination, resulting in successful, cross-compatible combinations of olive cultivars. Plus, the higher temperatures of Mirandela (southern to Valpaços’s olive groves) might favor a higher lipidic but a lower protein content. Also, diverse cultivation procedures and soil properties may play differential factors in the leaf composition as well. With respect to the distribution of lipids, it follows a waning order as follows: SFAs > MUFAs > PUFAs for all tested cultivars. The SFA relative composition profiles for all of the samples showed to be as follows: palmitic acid (C16:0) > stearic acid (C18:0) > lignoceric acid (C24:0); the stearic acid value was about 25% of the palmitic acid value for all cultivars, while lignoceric acid was about 6% of the palmitic acid for O. europaea Cobrançosa and about 10% for both O. europaea Madural and Verdeal. FAs are involved in the following mechanisms: disruption of the electron transport chain by binding to electron carriers, the leakage of cell metabolites via cell lysis, inhibition of nutrient uptake, and the formation of peroxidation/auto-oxidation products, resulting in cell deactivation [49]. The aforementioned mechanisms could be acting behind the antibacterial activity of the O. europaea Cobrançosa and Verdeal extracts against Salmonella Enteritidis (ATCC 13076); at once, according to Table 4, these same cultivars also displayed the highest values for MUFAs. On the other hand, regarding the whole PUFA composition, the whole sum of omega-6 FAs is much higher than the total omega-3 FAs for all of the tested extracts, with an emphasis on omega-6 linoleic acid. Omega-3 FAs showed a poor trace presence for all tested extracts. Among the selected cultivars, PUFA contents varied in the following order: O. europaea Cobrançosa (39.9%) > O. europaea Verdeal (39.74%) > O. europaea Madural (37.87%) (Table 4); considering PUFAs as essential FAs for the human body, both O. europaea Madural’s and Verdeal’s leaf extracts surge as valuable substrates compared to those of O. europaea Cobrançosa. Regardless, O. europaea Verdeal’s extract, relative to other cultivars, showed a higher content of both PUFAs and MUFAs.

3.2.2. TPC, TFC, and Antimicrobial Behavior of the Selected Cultivars

Several studies report that polyphenols derived from the olive tree are implicated in the relief and prevention of bioprocesses, such as through neurodegenerative, anti-hypertensive, and cardioprotective effects, whilst exhibiting anti-thrombotic, anti-inflammatory, antioxidant, anticancer, antimicrobial, and immune-protective properties [50,51]. The TPCs of the studied extracts were found to exhibit the following waning order: O. europaea Verdeal (59.30 ± 4.30 mgGAE/g sample) > Madural (48.90 ± 2.40 mgGAE/g sample) > Cobrançosa (37.90 ± 4.20 mgGAE/g sample) (Table 2), which are inferior to the values found for the same cultivars harvested from another geographical region in differential cultivation conditions, where O. europaea Cobrançosa (3.37 ± 0.25 mgGAE/g sample) > Verdeal (2.47 ± 0.2 mgGAE/g sample) > Madural (2.31 ± 0.22 mgGAE/g sample) [29]. Once again, O. europaea Verdeal’s leaf extract shows a relative higher level of TPC, which here is associated with a lower level of water content, suggesting it could be a potential source for extracting polyphenols of a high level of quality. On the other hand, O. europaea Verdeal’s leaves show the lowest level of protein and the highest As content among the three selected cultivars. For this, O. europaea Madural presents a better choice as a substrate for polyphenols, due to its TPC (Table 2) plus both, its high amount of protein (Table 2) and moderate water content (Table 2). With respect to the hypoglycemic and hypolipidemic properties already addressed in previous studies [52,53,54,55,56,57], the rich TPC in olive leaves, especially in the O. europaea Verdeal’s leaves of this work, makes them a possible tool for cardioprotective therapies as prophylactic and complementary measures, alongside their lower water content. The OLE of O. europaea Verdeal might also improve both insulin sensitivity and the secretory capacity of pancreatic β-cells, mimicking metformin effects in patients with type 2 diabetes mellitus (T2DM) [58]. So, if its As content is removed, this cultivar can also be suggested as a possible nutraceutical to regulate insulin resistance (IR) in developing endocrine disturbances. Among the TPCs found in the OLEs, hydroxytyrosol (HT) is referred to as the chief compound responsible for the biological properties of oleuropein (OLEP), mainly its high antioxidant potential [59]. HT has also been associated with innumerous favorable properties such as immuno-protective and antimicrobial activity [60,61], and anti-diabetic [62], anti-arrhythmic and cardioprotective [63], hypotensive and anti-atherosclerotic [64], anti-inflammatory [65], and antioxidant [66,67,68] effects. Besides HT, other phenolic compounds have shown to exhibit antibacterial effects against several strains of bacteria responsible for intestinal and respiratory infections in vitro [66,69,70,71], with promising results for applications as preservatives in food industry [23,62,72,73], in particular reducing the growth of Helicobacter pylori, which is associated with peptic ulcers and gastric cancer [66]. OLE polyphenols have also revealed antiviral and antiprotozoal activities [17,61,74,75,76]. The present study tested the inhibitory capacity of the OLEs from all three selected cultivars against Gram(+) strains—S. aureus (ATCC 25923), S. epidermidis (NCTC 11047), B. cereus (ATCC 14579)—and Gram(−) strains—E. coli (NCTC 9001), Salmonella Enteritidis (ATCC 13076), and P. aeruginosa (ATCC 10145). Inhibition tests exposed an overall greater efficacy against the tested Gram (−) strains compared to the tested Gram(+) strains, with the particular best results being achieved by O. europaea Madural’s and Verdeal’s leaf extracts against the Gram (−) P. aeruginosa (ATCC 10145) and the Gram(+) B. cereus (ATCC 14579). Although both the O. europaea Madural and Verdeal varieties displayed a broader antimicrobial activity against Gram (−) strains, the best result attained for their overall antimicrobial activity was found for Gram(+) B. cereus (ATCC 14579), with inhibition diameters of 10.67 ± 0.61mm and 11.30 ± 0.70mm, which represent about 172.6% and 163.0% of relative microbial inhibition when compared to lactic acid (the positive control), respectively. On the other hand, the OLE of O. europaea Cobrançosa reached higher efficacy against Gram (−) S. enteritis, with a relative inhibition of about 163.96% compared to the positive control. Regarding Gram(+) strains, the cultivar that showed a wider antimicrobial activity was O. europaea Verdeal, followed by O. europaea Cobrançosa and O. europaea Madural. The leaves of O. europaea Verdeal only displayed activity against S. aureus (ATCC 25923) besides B. cereus (ATCC 14579), with a result of about 126.74% compared to lactic acid. No antimicrobial activity was found for any sample of leaves against either S. epidermidis (NCTC 11047) or E. coli (NCTC 9001). Overall, the results indicated a higher efficacy of the OLE of the O. europaea Verdeal cultivar against B. cereus (ATCC 14579) > P. aeruginosa (ATCC 10145) > S. aureus (ATCC 25923), with inhibition diameters of about 11.30 ± 0.70 mm, 11.83 ± 1.01 mm, and 12.38 ± 0.60 mm, respectively (Table 6). The OLE of the O. europaea Madural cultivar displayed a higher antimicrobial efficacy against B. cereus (ATCC 14579) > P. aeruginosa (ATCC 10145) > Salmonella Enteritidis (ATCC 13076), with inhibitory zones of about 10.67 ± 0.61 mm, 11.44 ± 0.94 mm, and 13.54 ± 0.10 mm, respectively (Table 6). Lastly, the efficacy of the OLE of O. europaea Cobrançosa was superior against Salmonella Enteritidis (ATCC 13076) > P. aeruginosa (ATCC 10145) > B. cereus (ATCC 14579), with inhibition diameters of about 11.57 ± 0.80 mm, 13.04 ± 0.53 mm, and 13.16 ± 3.97 mm, respectively (Table 6). It is known that on one hand, higher C-reactive protein and IL-6 levels have been associated more with Gram(−) bacteria than Gram(+) bacteria [77,78], inducing greater inflammation and thus raising concern regarding the treatment of Gram(−) sepsis. On the other hand, the SCOPE project (Surveillance and Control of Pathogens of Epidemiologic Importance) in 2000, found that Gram(+) bacteria accounted for 76% of infections in health-compromised individuals, compared to this being only 14% for Gram(−) microorganisms [79,80]. Adding these concerns to the worldwide issue regarding multidrug-resistant (MDR) microorganisms such as B. cereus (ATCC 14579), S. aureus (ATCC 25923), and E. coli (NCTC 9001), researchers keep looking for sustainable solutions to downplay the overuse of antibiotics in the medical field. Such solutions include designing pharmacological actives based on natural resources, with the olive leaf extract being considered a top source due to its wide range of antimicrobial activities. Silver nanoparticles have proved able to stop Gram(+) and Gram (−) bacteria populations and exhibit a wide range of antibacterial action, so some researchers tested Ag nanoparticles/attapulgite nanocomposites using an OLE with antioxidant and antibacterial activity [81]. These researchers confirmed this ability of olive leaf waste to be valorized into silver nanoparticles and to act upon MDR bacteria with inhibition zones occurring at higher concentrations (100 µg/mL) [82]. Moreover, the inhibitory activity against MDR bacteria by composite OLE AgNPs was superior to that of the standard antibiotic. The authors explain that OLE bioactive groups surrounded the surface of the AgNPs, leading to superior antioxidant, antimicrobial, and anticancer activities [82]. These studies did not identify the type of cultivar they employed to synthetize the NPs, but from our work, it is possible to propose all of the tested cultivars to create AgNPs against Gram(+) B. cereus (ATCC 14579), while O. europaea Verdeal’s leaves show the most adequate matrix for producing green AgNPs against Gram(+) S. aureus (ATCC 25923). Our results also suggest O. europaea Madural to be the most suitable extract against Gram (−) P. aeruginosa (ATCC 10145), while O. europaea Cobrançosa and Verdeal are shown to be more appropriate against Gram (−) Salmonella Enteritidis (ATCC 13076). Phenolic compounds such OLEP, TY, and HT evidenced immuno-protective and antimicrobial properties [25,83], wherein the anti-Gram(+) and anti-Gram(−) effect that has been most studied and credited to phenolics is membrane disruption. The hydroxyl groups in phenolics lead to electron delocalization, making them act as proton exchangers and promoting bacterial membrane disruption and so leading to the cell’s death [49]. Regarding this aspect, the results showed that O. europaea Madural’s extracts displayed the top concentration of HT, though very close to that of O. europaea Verdeal. Interestingly, the O. europaea Madural extract achieved a higher antimicrobial efficacy against B. cereus (ATCC 14579) and P. aeruginosa (ATCC 10145), followed by O. europaea Verdeal and Cobrançosa, mirroring the amount of HT found in them. Both O. europaea Madural’s and Verdeal’s extracts displayed a higher content of HT: 10.86 ± 0.88 and 10.64 ± 0.15 mg/g dried extract, respectively (Table 3), accounting for 38.76% and 46.12% of the whole phenolic composition, respectively (Table 3). The HT content alone is insufficient to explain the antimicrobial behavior of O. europaea Verdeal against S. aureus (ATCC 25923) as well as that of O. europaea Cobrançosa against Salmonella Enteritidis (ATCC 13076). The phenolic profile assessed in the present study for O. europaea Cobrançosa was as follows, in waning order: HT > apigenin derivative > apigenin-7-O-glucoside > luteolin-7-O-glucoside > verbascoside. The extract from O. europaea Madural showed a phenolic composition very close to O. europaea Cobrançosa’s extract, switching only the third position for luteolin-7-O-glucoside and the fourth position to apigenin-7-O-glucoside. Considering that both apigenin-7-O-glucoside and apigenin derivates have been reported to possess antimicrobial properties [84,85], their higher concentration in O. europaea Cobrançosa, associated with its higher content of MUFAs, could be speculated as a possible reason for it achieving the best result against Salmonella Enteritidis (ATCC 13076), but further studies are needed. The present study also revealed for O. europaea Verdeal a slightly different profile compared to both other extracts, following the waning order of HT > apigenin derivative > luteolin-7-O-glucoside > verbascoside > apigenin-7-O-glucoside. Interestingly, researchers have reported that luteolin-7-O-glucoside exhibits antimicrobial activity [86] against S. aureus (ATCC 25923) [87,88,89], like verbascoside [90,91], speculating a possible explanation for the differential positive activity of the O. europaea Verdeal extract against this microbial.

3.2.3. Antioxidant Profile and Phenolic Composition of the Selected Cultivars

The TPCs of hydroethanolic extracts of O. europaea leaves showed to have relative higher presence in the following order: O. europaea Verdeal > O. europaea Madural > O. europaea Cobrançosa. The TFC results, however, showed another ranking: O. europaea Verdeal > O. europaea Cobrançosa > O. europaea Madural. Despite the highest TPC and TFC being shown by the leaf extract of O. europaea Verdeal, the results for the antioxidant activity of the OLEs showed O. europaea Madural > O. europaea Verdeal > O. europaea Cobrançosa regarding both FRAP and DPPH-RSA reactions, mirroring the TPC and HT content results. O. europaea Madural displayed very close values for both reducing and oxidizing power—FRAP and DPPH-RSA reactions, respectively. O. europaea Verdeal’s DPPH oxidizing power was close to that of O. europaea Madural, though the FRAP reducing power was comparatively lower, and for O. europaea Cobrançosa, the FRAP reducing power was higher comparatively to its DPPH oxidizing power. These differences in antioxidant and reducing behavior could be related to their relative composition of phenolic compounds. O. europaea Madural displayed the following profile for its antioxidant composition: HT > apigenin derivative > luteolin-7-O-glucoside > apigenin-7-O-glucoside, also associated to a stronger DPPH-RSA activity, like O. europaea Verdeal’s extract. On the other hand, O. europaea Cobrançosa’s extract displayed a second higher content of apigenin derivative following the content of HT, possibly related to a higher activity of FRAP compared to DPPH-RSA for the same cultivar. The highest content of HT and both glucosides of apigenin and luteolin could be behind this higher DPPH scavenging activity for the O. europaea Madural and O. europaea Verdeal extracts. O. europaea Cobrançosa’s leaves displayed the overall lowest value of TPC, at 37.90 ± 4.20 mg GAE/g sample, compared to the other two, despite displaying a TFC value very close to that of O. europaea Madural—30.40 and 29.10 mg ECE/g sample, respectively. Overall, the HT content showed to have a positive relation to the DPPH scavenging activity; this is in accord with review studies that have pointed out HT as a very significant bioactive compound mostly known for its high antioxidant efficiency, acting as a chain breaker by donating a hydrogen atom to peroxyl radicals (ROO) by the o-dihydroxyphenyl moiety and thus replacing the ROO by the unreactive HTyr* radical [92,93,94]. A similar antioxidant behavior can be associated to the hydroxyl group at the ortho position at 3’ on the B ring in the flavonoid nucleus, making a signature of the antioxidant activity by flavonoids [95]. However, in the present study, the action upon DPPH seems more related to phenolic action rather than that of the flavonoids. If not, the higher content of specific flavonoid compounds such as apigenin derivates and apigenin-7-O and luteolin-7-O glucosides, rather than the TFC, might actually be more related to the reducing power from F3+ to Fe2+ of the olive leave extracts, in particular of O. europaea Madural. An additional antioxidant behavior of HT is associated to the activation of different cellular signaling pathways, such as the induction of phase II detoxifying enzymes through the activation of nuclear factor erythroid 2-related factor 2 (Nrf2) in distinct tissues [96]. On the other hand, HT’s ability to modulate the expression of several microRNAs (miRNAs) [97] makes it thus a potential indirect molecular target to consistently promote the expression of functionality-related genes with intervention in biological processes, portraying HT as a frontrunner for therapeutic and/or nutraceutical interventions. Furthermore, in vitro and in vivo data confirm the reduction in pro-inflammatory compounds such as inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin (IL)-1β, as well as modulation of the immune response; however, the results for the scavenging activity of the olive leaf extracts against NO radicals were not conclusive [98]. Overall, with its hypocholesterolemic, anti-thrombotic, hypoglycemic properties, HT has been suggested to have therapeutic potential for the treatment of (1) atherosclerosis, acting as a potential mitochondria-targeting antioxidant in the inflamed endothelium, (2) postprandial lipidemia and hypercholesterolemia, with increases in endogenous vitamin C levels, and (3) platelet aggregation, with analogous results to acetylsalicylic acid. The antioxidant power of HT is also reflected in its anticarcinogenic potential, with positive effects in the prevention of several types of cancer [83,99,100,101,102]. Regarding its chemical properties that allow an easy formulation free of toxicity, HT has been highly regarded as a prime food supplement by the nutraceutical and food industries and so it is of key importance to potentiate the extraction of this phenolic compound from the olive leaf [61]. Concerning the premium choice, the O. europaea Madural leaf extract presents as a worthy nutraceutical due to its HT levels, confirming the invaluable multidimensional properties of olive leaves as a low-cost source of high-added-value phenolic compounds, as determined by other authors [30,31,51,99,103].

3.2.4. Vitamin E Composition of the Selected Cultivars

The present study reveals a non-significant presence of tocopherols, an evident difference in relation to our previous study [29], where the OLEs’ tocopherol profiles varied in the waning order of O. europaea Verdeal (21.6 mg/100 g) > O. europaea Cobrançosa (18.79 ± 0.54 mg/100 g) > O. europaea Madural (12.03 ± 0.11 mg/100 g). In addition, from the overall content of tocopherols, it was also possible to identify α-T as the major isomer [29], with a waning order of 97.04% (O. europaea Verdeal) > 96.01% (O. europaea Madural) > 95.37% (O. europaea Cobrançosa). This difference may be due to both distinct cultivation procedures and the geographic location of the groves. The present study used samples of olive leaves collected in Mirandela within an orchard where the olive trees were distributed heterogeneously in the field, while in the previous study, the samples were harvested in Valpaços, where the olive groves were planted separately by cultivar. α-T is known for its antioxidant value in inhibiting lipid peroxidation, particularly within cell membranes rich in PUFAs, thus sustaining their integrity [104]. α-tocopherol is the core form of vitamin E, with the highest tissue concentration, but α- forms of both tocopherols and tocotrienols are considered the most metabolically active, with tocotrienols showing a higher antioxidant activity in in vivo systems [105]. The oral bioavailability of E vitamins is significantly limited as they are not recognized by the αT transfer protein (α-TTP), and recent studies suggest an alternative mechanism of intracellular transport of α-tocotrienol [106]. With respect to the identification of tocotrienols in OLEs, previous studies have not shown that there is a significant presence of this compound [29,107], but as different geographical regions induce diverse organic profiles, it would be interesting to broaden the study of tocotrienol levels in OLEs from diverse origins to understand if any of them possess the potential to be a source of both α- forms of tocopherols and tocotrienols and their possible use to mitigate neuro-inflammatory processes.

3.2.5. Enzymatic Inhibition by the Selected Cultivars

Acetylcholinesterase (AChE) is responsible for the enzymatic cleavage of the neurotransmitter acetylcholine (ACh), for it is the main target for the mitigation of Alzheimer’s disease (AD), being present in both the central and peripheral nervous system and in muscular motor plaques [108]. Butyrylcholinesterase (BChE) is up-regulated in advanced AD, and it can be found in the brain, peripheral tissues, and in serum [108]. No drug has been approved to prevent neuronal cell loss in patients suffering from PD or AD once the “one protein, one target” strategy falls behind when addressing multifactorial neurodegenerative disorders. In contrast, restoring neurotransmitter levels by combinatorial inhibition of cholinesterases, monoamine oxidases, and adenosine A2A A receptors, to counteract oxidative stress and beta-amyloid plaque accumulation, would establish a therapeutically strong multitarget approach [109]. Latest studies have shown that butyrylcholinesterase (BuChE) inhibitors or double acetyl and butyryl cholinesterase inhibitors exhibit enhanced restorative effects on AD with less side effects than specific AChE inhibitors [108]. According to the literature, OLE reduces the activity of AChE and induces glutathione S-transferases in a dose–response manner [110,111]. Interestingly, the present study showed that all extracts could inhibit both AChE and BChE, with higher results against AChE: O. europaea Madural > O. europaea Verdeal > O. europaea Cobrançosa. Former studies have associated the role of specific compounds such as luteolin-7-O-glucoside to the enzymatic inhibition of AChE [89], which is coherent with the findings of a higher value of this flavone in O. europaea Madural compared to both other cultivars.
Monoamine oxidase (MAO) catalyzes the oxidative deamination of neurotransmitter monoamines and a variety of xenobiotic and dietary amines. Two MAO isoforms, namely MAO-A and MAO-B, are localized in the mitochondrial outer membrane and show different substrate specificities—MAO-A prefers serotonin, whereas MAO-B prefers phenylethylamine and benzylamine. Although most marketed MAO drugs are long-lasting irreversible inhibitors, reversible inhibitors have been developed to avoid prolonged irreversible effects: for example, moclobemide and safinamide, which are selective for MAO-A and MAO-B, respectively, and are prescribed as an antidepressant and for the treatment of PD, respectively [109,111,112]. Since both cholinesterases and monoamine oxidases are closely associated with AD and PD symptomatology and progression, they have been tackled simultaneously using several multifunctional ligands [109]. On one hand, several herbal extracts perform combined actions aimed at multiple receptors; on the other hand, the discovery of active natural products (i.e., secondary metabolites) can be either employed in clinical studies or function as important frames to design novel synthetic agents. Regarding the importance of cholinesterase and monoamine oxidase B for the treatment of AD and PD, innovative natural agents concomitant to novel biological activities present in known natural products have been explored in the last decade [111]. In the present study, an overall higher inhibition of MAO-A compared to MAO-B was observed, as follows: O. europaea Madural > O. europaea Cobrançosa > O. europaea Verdeal, wherein the IC50 for MAO-A was attained at concentrations of 194.1 µg/mL, 251.1 µg/mL, and 294.4 µg/mL, respectively (Table 8). These results are coherent with previous authors associating the inhibitory activity of MAO with specific flavones such as apigenins and luteolins [113]; however, further compound isolation studies of our samples are required to verify this premise. Still, the dual ability of the leaf extract from O. europaea Madural to inhibit AChE and MAOs surges as an interesting natural target for designing innovative pharmacological solutions to address AD and PD, or even depression.
Currently available ACE and renin inhibitors help to reduce the complications of hypertension; however, most patients require two or more anti-hypertensive medications to achieve their blood pressure (BP) goals (<140/90 mm Hg or <130/80 mm Hg for those with diabetes or chronic kidney disease), translating into an elevated risk of adverse drug reaction and a rise in medication costs [114]. An interesting alternative for upgrading efficacy while reducing therapeutic costs is the resource of potential herbal medicines, since their phytochemicals can either act directly on blood vessels through a vasorelaxant effect or indirectly through inhibition or stimulation of diverse systems, such as ACE, renin–angiotensin system (RAS), or diuretic activity [115]. The anti-hypertensive and cholesterol-lowering actions of olive leaves are well documented [21], as well as their hypotensive bioactives such as oleuropein, oleacein and oleanolic acid, flavonoids, alkaloids, tannins, and terpenoids [116,117]. OLE taken at 1000 mg daily effectively lowered systolic and diastolic blood pressures in subjects with stage-1 hypertension, with a comparable effect to a Captopril® dose of 12.5–25 mg twice daily [118]. The present study showed an overall higher inhibition of renin activity compared to ACE with no possible dose distinction between OLEs of different cultivars. Regarding ACE inhibition, it follows an increasing order of O. europaea Cobrançosa< O. europaea Madural< O. europaea Verdeal, wherein the IC50 for ACE was attained at concentrations of 712.5 µg/mL, 553.2 µg/mL, and 442.4 µg/mL, respectively (Table 9). Considering the arsenium content in O. europaea Verdeal’s leaves, the O. europaea Madural leaf extract may be a good option as a source of natural compounds to reduce BP with it achieving the best inhibition of ACE and renin, revealing the best dual activity for BP modulation and so being an alternative to combinatory drug therapy.

4. Materials and Methods

4.1. Chemical Reagents

For the inorganic analyses, absolute ethanol was obtained from Fisher Chemical® (Loughborough, England), and methanol, gallic acid, Folin–Ciocalteu reagent, sodium carbonate (Na2CO3), boron trifluoride (BF3), and 1,4-dioxane were purchased from Sigma (St. Louis, MO, USA). Nitric acid (HNO3), hydrogen peroxide (H2O2), Kjeldahl tablet catalysts, sulfuric acid, boric acid, potassium hydroxide (KOH), anhydrous sodium sulfate (Na2SO4), and n-hexane (HPLC grade) were obtained from Merck® (Darmstadt, Germany). Tocol (2-methyl-2-(4,8,12-trimethyl-tridecyl) chroman-6-ol) was obtained from Matreya Inc.® (State College, PA, USA). Vitamin E standards were from Calbiochem® (La Jolla, CA, USA). Water was purified in a Milli-Q system® (Millipore, Bedford, MA, USA). For the analyses of biological activities, we used Tris(hydroxymethyl)aminemethane (Tris), 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), acetylthiocholine iodide (ATCI), S-butyrylthiocholine iodide (BTCI), acetylcholinesterase (AChE) of Electrophorus electricus, butyrylcholinesterase (BuChE) of equine serum, bovine serum albumin (BSA), monoamine oxidase A (human recombinant MAO-A), monoamine oxidase B (human recombinant MAO-B), kynuramine, renin assay kit (MAK157), angiotensin-I-converting enzyme (ACE) activity assay kit (fluorometric) (CS0002), potassium phosphate monobasic (KH2PO4), potassium phosphate dibasic trihydrate (K2HPO4·3H2O), sodium nitroprusside dihydrate (SNP), sulfanilamide, naphthylethylenediamine dihydrochloride, ortho-phosphoric acid 85%, 2,2-diphenyl-1-picrylhydrazyl (DPPH), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), potassium persulfate (K2O8S2), sodium carbonate, Folin–Ciocalteau reagent, gallic acid, boron trifluoride–methanol (BF3) at 14% methanol, butylated hydroxytoluene (BHT) (≥99%), and sodium nitrite were purchased from Sigma-Aldrich® (St. Louis, MO, USA and Steinheim, Germany). Fatty acid methyl ester standard mixture (FAME) Supelco 37 was obtained from Supelco® (Bellefonte, PA, USA). Epicatechin was obtained from Extrasynthèse® (Genay, France). Magnesium chloride hexahydrate and sodium chloride were obtained from VWR® (Leuven, Belgium). Sodium hydroxide and anhydrous sodium sulfate were obtained from Pronalab® (Lisbon, Portugal). Dichloromethane and n-hexane (99%) from Merck® (Darmstadt, Germany). Methanol from VWR Chemicals Prolabo® (Fontenay-sous-Bois, France). Tridecanoic acid (C13:0) was obtained from Fluka® (Switzerland) and sodium chloride (99.5%) was from Panreac® (Barcelona, Spain). Aluminum chloride was purchased from Honeywell Fluka® (Seelze, Germany). Standards for HPLC were purchased from Extrasynthèse® (hydroxytyrosol, tyrosol, verbascoside, apigenin-7-O-glucoside, luteolin-7-O-glucoside), Fluka® (caffeic acid), and Sigma-Aldrich® (α-tocopherol, β-tocopherol, δ-tocopherol, and γ-tocopherol). PTFE 0.45 μm filters were purchased from VWR International® (PA, USA). Ultrapure water (resistivity of 18.2 MΩ cm at 25 °C) was produced using a Simplicity 185 system (Millipore, Molsheim, France). The eluents used in the HPLC-DAD analyses were methanol Chromasolv for HPLC from Riedel-de Haën® (Seelze, Germany) and formic acid from Carlo Erba® (Val de Reuil, France), which were filtered through a 0.22 μm nylon membrane filter (Fioroni Filters, Ingré, France) using a vacuum pump (Dinko D-95, Barcelona, Spain) and degassed for 15 min in an ultrasonic bath (Sonorex Digital 10P, Bandelin DK 255P, Germany).

4.2. Sample Collection

The olive leaf samples were harvested from an olive grove in Vale Salgueiros, Mirandela region, during the month of May 2022. These samples belonged to three different cultivars: O. europaea Madural (Figure 6A,B), O. europaea Cobrançosa (Figure 7A,B), and O. europaea Verdeal (Figure 8A,B), randomly mix-cultivated within the same grove. The olive grove’s coordinates in WGS84 are Lat: 41.579700 and Long: −7.241642. The main reason for the choice of these O. europaea cultivars is their strategic importance for obtaining the finest and most-desired organoleptic and physio-chemical properties in a premium olive oil with DOP (Protected Designation of Origin) excellency. All through the cycle of olive oil production, a bulky load of O. europaea leaves has to be disposed of, causing substantial costs for both olive farmers and oil manufacturers. Finding a way to upcycle these leaves based on the discriminated properties of each cultivar would not only create an economic and environmental value-adding route, but also a potential horizon for expansion in pharmaceutical and medical fields, food production, and preservation technologies, while respecting the basic principles of wise, good, and local established origins of raw material.
This production is embedded in a total area of 13.5 ha equivalently distributed with (1) 59.26% (8.0 ha) of O. europaea Cobrançosa, (2) 10.37% (1.4 ha) of O. europaea Madural, and (3) 30.37% (4.1 ha) of O. europaea Verdeal cultivars. On average, the allocation of olive trees/area is approximately 200 items/49 m2, being even denser in topographical planes. Soil mobilization was carried out through tillage. These cultivars were treated through the seasons with pesticides or herbicides properly certified for agroproduction, in coherence with an integrated protection program which allows the sustainable use of these products with reduced human health and environmental risks. This strategy promoted phytosanitary protection with the least-possible disturbance to agricultural and agroforestry ecosystems while encouraging natural mechanisms adverse towards plagues. According to our analysis of the leaves collected from the ground, the evidence suggested the use of a blend composed of (1) a calcium sulfate complex (Bordeaux mixture without copper), (2) Sprintplus (algae-based), and (3) mixed organic matter with soil revitalizers in the culture soil.

4.3. Sample Preparation and Extraction Procedure

Three varieties of O. europaea L. folium (O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal) were collected and ground in a mill (Retsch Knife Mill GRINDOMIX GM 200, Retsch, Haan, Germany). For inorganic evaluation, 0.2 g of each sample of milled dry leaf was digested by microwaves (MW) within a closed system at 170 °C using 1 mL of HNO3, 2 mL of H2O2, and 1 mL of H2O. After cooling, the vessel contents were transferred to volumetric flasks and the volume was increased to 25 mL by adding deionized water [39]. The samples for bioactive compound analysis were obtained by subjecting 0.60 g of milled dry olive leaves from each cultivar to an organic extraction procedure with 12 mL of an ethanol/water mixture (50/50, v/v) during 60 min at 55 °C. After extraction, the solvent was evaporated under reduced pressure [29]. The purpose of this work was to determine the presence and quantity of already-known compounds from previous studies [32,39] with these types of cultivars, for which no work of MS and HPLC has been performed for the characterization of their extracts.

4.4. Water Content

The assessment of humidity was determined in triplicate through infrared hygrometry readings at 105 °C using 1 ± 0.1 g of milled leaves from each sample (infrared balance, Scaltec model SMO01, Scaltec Instruments, Heiligenstadt, Germany).

4.5. Quantification of Inorganic Elements

Mineral measurements of O. europaea L. folium were obtained using inductively coupled plasma mass spectroscopy (ICP-MS) on a Thermo ICP-MS X Series equipped with a Burgener nebulizer. This system functions with a plasma power at 1400 w, an argon flux of 13 mL/min, an auxiliary gas flux of 1 mL/min, and a sample flux of ~1mL/min. The tuning procedure was performed daily using a multielement solution (6Li, In, Ce, U: 10 µg/L each) and the response for oxides (140Ce16O/140Ce ratio) did not exceed 2%. External calibration was performed using a multielement standard solution in 1% nitric acid (v/v) at the following element concentration levels: 0, 0.2, 0.4, 1.0, 2.0, 5.0, 10, 50, and 100 µg/L for minor constituents, and 0, 0.02, 0.04, 0.1, 0.2, 0.5, 1, 5, and 10 mg/l for major elements. The internal standard (10.0 µg/L 115In) was added online. Each analysis was carried out in triplicate readings per solution sample [39].

4.6. Proximate Organic Composition

Proximate composition analyses of the three olive tree leaf varieties were performed in triplicate, according to AOAC (2000, 2005, 2006) methods [32,33,34,35]: dry matter (in an oven at 105 °C to constant weight; P Selecta, Barcelona, Spain); ash (incinerated at 500 °C for 6h in a muffle furnace; Nabertherm B-180, Lilienthal, Germany); protein quantitation via the Kjeldahl method (AOAC, 2000) using a digestor (DK6 digester, Velp Scientific, Usmate, Italy) followed by distillation (Keltec System 1002, Foss Tecator, Hilleroed, Denmark) and titration. Total lipids were extracted and quantified according to Folch et al., 1957 and using Folch solution (dichloromethane–methanol 2:1 v/v with 0.01% butylated hydroxytoluene—BHT) [35].

4.7. Total Phenolic Content (TPC)

TPC values were determined via colorimetric assays based on Folin–Ciocalteu reagent, which reacts with reduced phenols to produce a stable blue product at the end of the reaction. The reaction mixture consisted of 25 μL of the sample or standard solution, 75 μL of deionized water, and 25 μL of Folin–Ciocalteu reagent (50× dilution). After 6 min in the dark, 100 μL of Na2CO3 (75 g/L) was added. Absorbance was measured at 765 nm, after a 90 min incubation at room temperature. Calibration curves were calculated using gallic acid (GA). Each experiment was carried out in triplicate and the results were expressed as the gallic acid equivalent (GAE) per gram of sample [119].

4.8. Total Flavonoid Content (TFC)

TFC values were determined via colorimetric assays based on the formation of flavonoid–aluminum compounds [119]. The reaction mixture consisted of 25 μL of a diluted sample, 100 μL of ultrapure water and 10 μL of 5 g/100 mL NaNO2 solution. After 5 min, 15 μL of 10 g/100 mL AlCl3 solution was pipetted, and after 1 min, 50 μL of 1 mol/L NaOH was also added. The solution was well mixed, and absorbance was read at 510 nm. Calibration curves were prepared with epicatechin, and the results were expressed as milligrams of epicatechin equivalent (ECE) per gram of sample. The experiment was carried out in triplicate.

4.9. Phenolic and Tocopherol Profiles

Twenty microliters of each extract was analyzed (n = 3) on an analytical HPLC unit (Shimadzu) composed of a low-pressure quaternary pump (model LC-20AT), a degasser (model DGU-20A5R), an auto-sampler (model SIL-20AT), a column oven (model CTU-20AC), and a photodiode array detector (model SPD-M20A High-Performance Liquid Chromatography PDA Detector) at 25 °C. Compound separation was achieved with a C18 Spherisorb ODS2 (25.0 × 0.46 cm; 5 μm particle size) column from Waters (Ireland). The solvent system consisted of formic acid 5% (A) and methanol (B), starting with 5% B, and installing a gradient to obtain 15% B at 3 min, 25% B at 13 min, 30% B at 25 min, 35% B at 35 min, 45% B at 39 min, 45% B at 42 min, 55% B at 47 min, 75% B at 56 min, 100% B at 60 min, 100% B at 65 min, and 5% B at 66 min, stopping at 80 min. The solvent flow rate was 920 μL/min. Spectral data from all peaks were collected in the range of 200–600 nm, and chromatograms were recorded at 280, 320, 340, and 350 nm. Data were processed on LabSolutions software. Compounds were identified by comparing their retention times and UV–vis spectra with standards injected in the same conditions and/or by comparison with the literature [28,120]. External calibration curves were prepared to quantify the identified compounds in the samples, using six concentrations (n = 3, each concentration): hydroxytyrosol (y = 5.23 × 106x + 1.33 × 104; R = 0.9998), tyrosol (y = 5.63 × 107x + 6.54 × 104; R = 0.9998), caffeic acid (y = 1.34 × 108x − 9.92 × 104; R = 0.9997), verbascoside (y = 3.76 × 107x + 3.19 × 104; R = 0.9998), apigenin-7-O-glucoside (y = 5.97 × 107x − 4.90 × 104; R = 0.9998), and luteolin-7-O-glucoside (y = 5.98 × 107x − 1.80 × 105; R = 0.9995). Peak areas were recorded at 280 nm for hydroxytyrosol and tyrosol, at 320 nm for caffeic acid and verbascoside, at 340 nm for apigenin-7-O-glucoside and an apigenin derivative, and at 350 nm for luteolin-7-O-glucoside. The identified compounds were quantified with their corresponding standards, except the apigenin derivative, which was quantified as apigenin-7-O-glucoside. Tocopherol profiles were determined with the same runs performed for the phenolic profile but using the RF-20A-XS fluorescence detector. Calibration curves of α-tocopherol (y = 7.64 × 108x + 3.17 × 105; R = 0.9987), β-tocopherol (y = 1.16 × 109x + 1.34 × 107; R = 0.9912), γ-tocopherol (y = 1.04 × 109x + 7.67 × 106; R = 0.9965), and δ-tocopherol (y = 3.91 × 109x + 1.75 × 107; R = 0.9885) were prepared from 5 concentrations of standards (n = 3, each concentration). Each compound’s identity was assessed by comparing their retention times with their corresponding standards injected in the same conditions.

4.10. Lipid Profile

4.10.1. Lipid Extraction

Around 2 g of the ground sample was introduced into a cellulose cartridge (cellulose extraction thimbles 25 × 60 mm) and lipid extraction was performed via Soxhlet (Soxtest Trade Raypa) with 50mL of a mixture of n-hexane–dichloromethane (50:50) for 7 h at 110 °C. The final extract was placed in a previously weighted glass tube and the solvent was evaporated on a rotatory evaporator (Rotavapor® R-200; Buchi, Flawil, Switzerland) at 40 °C with vacuum. After 24 h in the desiccator, the tube was weighed [36].

4.10.2. Determination of Fatty Acids

The lipid residue previously obtained was re-diluted in 4 mL of n-hexane and 2 mL of dichloromethane. To 3 mL of these diluted extracted, we added 37.5 mg of activated carbon. After vortexing and centrifugation, 2 mL was taken and 5 mL of sodium methanolate solution (NaOMe) at 0.5 M was added. Following new vortex agitation, the samples were heated to 100 °C for 10 min and cooled for 5 min in ice. Then, 5 mL boron trifluoride-methanol was added, and the samples were again heated to 100 °C for 30 min and cooled in ice for 5 min. Then, 1 mL of n-hexane with butylated hydroxytoluene (BHT) at 0.02% was added. The tubes were shaken in a vortex, and 2 mL of sodium chloride was added and centrifuged for 10 min at 2500 rpm. The top layer was retrieved and dried with anhydrous sodium sulfate [37,121]. Then, 150 µL was taken and evaporated to dryness with nitrogen and finally re-diluted in 150 µL of n-hexane. Gas chromatography analyses were performed on Shimadzu GC- 2010 equipped with a flame ionization detector (FID) and a Shimadzu AOC-20i auto-injector. Separation of FAMEs was carried out on an Agilent® J&W Cp-Sil 88 capillary column (60 m × 0.25 mm I.D., 0.20 µm) from Santa Clara, USA. The operating conditions were as follows: a split–splitless injector was used in split mode with a split ratio of 1:50; the injection volume of the sample was 1.0 µL; the injector and detector temperatures were kept at 250 °C and 260 °C, respectively; and the temperature program was as follows: initial temperature 100 °C for 5 min, increased at 3 °C/min to 183 °C and held for 3 min, raised at 0.5 °C/min to 195 °C held for 3 min, increased again at 0.5 °C/min to 200 °C, and finally raised at 2 °C/min to 220 °C held for 12.33 min. The carrier gas was He 30 mL/min and the detector gas flows were as follows: H2, 40 mL/min; air, 400 mL/min. Fatty acid methyl esters were identified by comparison with known standard mixtures (Sigma 47,885-U Supelco 37 Component FAME Mix, USA) and quantified using the software GCsolution for GC systems (Shimadzu), as described previously [122]. FA contents (expressed in %) were obtained for each fatty acid and total FA area ratio.

4.11. Antioxidant Activity

4.11.1. DPPH Radical Scavenging Activity

The DPPH-RSA of samples was determined spectrophotometrically at 517 nm against the stable nitrogen radical DPPH radical. DPPH radical is reduced to the corresponding hydrazine when it reacts with hydrogen donors, such as an antioxidant. In this technique, samples (25 μL) were mixed with 200 μL fresh ethanolic solution of DPPH radical, 0.04 mg/mL. The mixture, vigorously shaken, was left to stand for 30 min in the dark (until stable absorption values were observed) [119]. Calibration curves were prepared with Trolox solutions and the results were expressed as the Trolox equivalent (TE) per gram of sample. The experiment was carried out in triplicate.

4.11.2. FRAP Assay

The FRAP method corresponds to the reduction, at acid pH, of the complex Fe3+-TPTZ to Fe2+-TPTZ, which is blue at 593 nm. FRAP determinations were obtained by adding 20 μL of sample to 180 μL of FRAP reagent (Fe3+-2,4,6-Tri(2-pyridyl)-s-triazine), 0.833 mmol/L. The solution was incubated at 37 °C for 4 min for color development and the absorbance was measured at 593 nm [119]. Calibration curves were prepared with ascorbic acid (AA) solutions and the results were expressed as the ascorbic acid equivalent (AAE) per gram of sample. The experiment was carried out in triplicate.

4.11.3. NO Scavenging Activity

The procedure adopted was previously described in Soares et al., 2021 [37]. One hundred microliters of sodium nitroprusside was incubated with 100μL of sample (2000, 1000, 500, 250, 125, 63 µg/mL) for 60 min, at room temperature, under light. After incubation, 100 μL of Griess reagent (composed of 1% sulfanilamide and 0.1% naphthylethylenediamine in 2% phosphoric acid) was added to each well. The mixture was incubated at room temperature for 10 min, and the absorbance was read at 560 nm (Biotek Synergy HT microplate reader). Phosphate buffer was used as negative control and 2% phosphoric acid, instead of the Griess reagent, was added to the blanks.

4.12. Enzyme Inhibition

4.12.1. AChE and BuChE Inhibition

The inhibition of AChE and BuChE activity was measured according to a modified Ellman method previously reported [37]. Briefly, the extracts were dissolved in Tris-HCl buffer (50 mM, pH = 8) to prepare different dilutions (2000, 1000, 500, 250, 125, 63 µg/mL). Then, 25 µL of each extract dilution was added to the wells, plus 125 µL of DTNB reagent, 50 µL of buffer B (Tris-HCl buffer + 0.1% albumin), 25 µL of ATCI/BTCI, and 25 µL of 0.44 U/mL AChE solution or 0.40 U/mL BuChE solution. Slopes were calculated from the kinetic curve obtained at 405 nm and 37 °C in a total reaction time of 1 min 44 s. Blanks were prepared by substituting the enzymes for buffer B, and Tris-HCl buffer (instead of the extracts) was used as a negative control.

4.12.2. MAO-A and MAO-B Inhibition

The MAO-A/B inhibition assay was based on the production of 4-hydroxyquinoline from kynuramine deamination, according to Soares et al., 2021 [37]. Six dilutions of each extract were prepared in 0.1 M KH2PO4/K2HPO4 (pH 7.4), namely, 1000, 500, 250, 125, 63, and 32 µg/mL. Two hundred and fifteen microliters of each dilution was mixed with 10 µL of 3.75 mM of knuramine. The reaction was started by adding 75 µL of 17 U/mL MAO-A or MAO-B solution. Negative controls (without extract) and blanks (without enzyme) were also prepared. The production of 4-hydroxyquinoline was determined by measuring the absorbance at 314 nm with a Synergy HT (Biotek Instruments) microplate reader during incubation at 37 °C for 70 min.

4.12.3. Angiotensin Converting Enzyme (ACE) Inhibition

The ability of the extracts to inhibit ACE was measured with an angiotensin-I-converting enzyme (ACE) activity kit (Sigma-Aldrich, CS0002). Briefly, each well contained 50 μL of each extract dilution (2000, 1000, 500, 250, 125 µg/mL) or 50 μL of buffer solution (in case of the negative control), 20 μL of ACE solution (diluted 500-fold in assay buffer), and 50 μL of substrate (diluted 100-fold in assay buffer). Sample blanks were prepared by substituting the enzyme for buffer. Measurements were carried out at 37 °C, using Ex/Em = 360/40, 460/40, in kinetic mode, in 5 cycles for 5 min.

4.12.4. Renin Inhibition

The ability of the extracts to inhibit renin was measured with a renin assay kit (Sigma-Aldrich, MAK157). Briefly, each well contained 50 μL of each extract dilution (2000, 1000, 500, 250, 125 µg/mL) or 50 μL of buffer solution (in case of negative control), 20 μL of renin solution (1 μg/mL), and 50 μL of substrate (diluted 100-fold in assay buffer). Sample blanks were prepared by substituting the enzyme for buffer. Measurements were performed at 37 °C, using Ex/Em = 485/20, 590/35, in kinetic mode, collecting data every five minutes for 60 min.

4.13. Antimicrobial Activity

4.13.1. Microorganisms and Culture Conditions

The antimicrobial activity of the olive tree leaf extracts was assessed against the following Gram-positive bacterial strains: Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis (NCTC 11047), and Bacillus cereus (ATCC 14579); and the following Gram-negative strains: Pseudomonas aeruginosa (ATCC 10145), Salmonella Enteritidis (ATCC 13076), and Escherichia coli (NCTC 9001). Bacterial strains were stored at −80 °C in glycerol–water (15:75, v:v). Prior to running the experiments, active cultures were grown in sterile Mueller–Hinton broth (MHB) at 37 °C, overnight. Then, an aliquot from each culture was transferred to fresh MHB and properly diluted to achieve an optical density of 0.09–0.11, measured at 600 nm (Clinical and Laboratory Standards Institute, 2012), corresponding to the 0.5 MacFarland standard to reach 1–2 × 108 colony formation units (CFUs) for further assays.

4.13.2. Agar Diffusion Assay

This assay followed the adapted protocol from the CLSI guidelines (Clinical and Laboratory Standards Institute, 2012). Briefly, 5 mL of each extract was evaporated until dryness under a nitrogen flow at 25 °C to minimize oxidation. The remaining residue was dissolved in 2 mL of DMSO, and filter-sterilized through 0.45 μm pore-size syringe filters. Later, 100 μL of such suspensions for every microorganism were seeded in Petri dishes containing Mueller–Hinton II agar and spread with sterile swabs. Plates were divided into four sections, including 15 μL of each tested extract (test section), DMSO (negative control section), and 40% lactic acid (positive control section). Once cultivated, the plates were incubated at 37 °C for 24 h. Growth inhibition was quantified in inhibition circular zones, and their diameters were measured using a digital caliper rule. Triplicate plates were assessed for each microorganism.

4.14. Statistical Analysis

Statistical analysis was performed using IBM SPSS Statistics (v. 26 for Windows, IBM Corp., Armonk, 241 NY, USA). The evaluation of statistical significance was determined by ANOVA and Tukey’s HSD to assess significant differences between the samples at a 5% significance level.

5. Conclusions

The inorganic profile of OLEs from different cultivars makes them a practical and inexpensive source of mineral substrates for addressing disorders related to deficiencies of essential elements such as Ca, K, Mg, Mn, Fe, and Cu, particularly proposing O. europaea Madural’s OLE to address hypocalcemia and hypomagnesemia; Verdeal’s for hypokalemia and for Mn deficiency, if its As is properly removed; and O. europaea Cobrançosa’s to address hypocupremia and sideropenia. The extract from O. europaea Madural’s leaves could be the most useful one for retaining a high-quality phenolic composition given the water content and TPC, making it a possible natural matrix for (1) cardioprotective therapies as a prophylactic and treatment agent, and (2) improving both the insulin sensitivity and (3) secretory capacity of pancreatic β-cells, thus mimicking metformin’s effects in patients with T2DM. Considering the variability patterns and differences in the parameters analyzed for the chemical profile of each OLE, it seems that the phenolic compounds—particularly HT and flavones as apigenin derivatives—are the key compounds responsible for the antimicrobial activity described. Nevertheless, other components such as the total composition of FAs such as MUFAs and PUFAs are possible synergistic factors, along with phenolics and flavonoids acting against bacteria together rather than acting solo. O. europaea Madural and Cobrançosa can be proposed as possible materials for formulating green and safe AgNPs to be used as antioxidants and as an alternative antibiotic against some MDR microorganisms in the future, since they are non-toxic, environmentally friendly, and affordable. In particular, the higher TPC and TFC of O. europaea Verdeal’s leaf extract makes it valuable against Gram(+) S. aureus (ATCC 25923), while O. europaea Madural’s leaves, rich in HT, showed the highest activity against the Gram-negative P. aeruginosa (ATCC 10145), and MUFA-rich O. europaea Cobrançosa showed to be more effective against Salmonella Enteritidis (ATCC 13076). Given its higher capacity to inhibit both AChE, BuChE, and MAO-A, O. europaea Madural’s leaf extract may be proposed as a natural multitarget treatment for AD, PD, and depression. Moreover, due to it lacking the arsenic toxicity present in the samples of O. europaea Verdeal and its favorable inhibition of both renin and ACE, O. europaea Madural’s leaf extract exhibits the best dual activity for BP modulation and so presents an alternative for combinatory drug therapy. This work confirms the multifaceted ability of olive leaves to be regarded as an olive tree byproduct to be exploited as a low-cost source of high-added-value phenolic compounds, displaying a variable profile of nutritional and biochemical criteria when changing parameters such as the orchard location, climate, and type of cultivation. It is known that Olea europaea L. is a wind-pollinated crop with a diverged bearing pattern [123]. Fruit and leaf features can be improved through numerous strategies to define the most successful compatible combinations of cultivars. A mixed cultivation of different varieties within the same area might lead to naturally selected crossbreeding, favoring certain properties. So, certainly, the dissimilarity in findings for the studied parameters between the present and the previous studies might be due to both geographic and climatic diversity, but also, to some degree, modification in the crop genotype. For verifying this influence on the newfound parameters’ variance, it would be recommended to follow this work with new studies regarding seed paternity analyses/genetic surveys of leaf samples, planned, for example, on microsatellite markers specified for the identification of potential pollen donors from the three cultivars that have shared this mixed olive orchard for over 60 consecutive years.

Author Contributions

Conceptualization, J.M. and C.G.; methodology, M.F.B., A.S., S.S. and V.F.D.; software, L.L. and M.H.C.; validation, J.M. and C.G.; formal analysis, N.M.d.O., J.M., C.G., A.S., S.S. and V.F.D.; investigation, N.M.d.O., M.F.B., A.S., S.S. and V.F.D.; resources, J.M., L.L. and C.G.; data curation, C.G.; writing—original draft preparation, N.M.d.O.; writing—review and editing, M.F.B., A.S., S.S., V.F.D., J.M. and C.G.; visualization, N.M.d.O. and J.M.; supervision, J.M.; project administration, J.M.; funding acquisition, J.M. All authors have read and agreed to the published version of the manuscript.

Funding

The authors acknowledge funding from Instituto de Ciências Biomédicas de Abel Salazar,—Universidade do Porto (ICBAS-UP), School of Medicine and Biomedical Sciences, regarding research resources, logistics, and APC costs.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in this article. Further inquiries can be directed to the corresponding author.

Acknowledgments

The authors are grateful to the kindness of the farm owners from Vale de Salgueiros, Mirandela region, who made it possible to access biological samples of three Portuguese variants of olive leaf grown in mixed cultivation in the same geographic location for analysis in the present study. Furthermore, the authors are grateful to ICBAS for supporting their research and revival of homeland plant varieties as a push for local and sustainable agriculture to incentivize domestic economic development.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Passeri, V.; Sammut, C.; Mifsud, D.; Domesi, A.; Stanzione, V.; Baldoni, L.; Mousavi, S.; Mariotti, R.; Pandolfi, S.; Cinosi, N.; et al. The Ancient Olive Trees (Olea europaea L.) of the Maltese Islands: A Rich and Unexplored Patrimony to Enhance Oliviculture. Plants 2023, 12, 1988. [Google Scholar] [CrossRef]
  2. Ronca, C.L.; Marques, S.S.; Ritieni, A.; Giménez-Martínez, R.; Barreiros, L.; Segundo, M.A. Olive Oil Waste as a Source of Functional Food Ingredients: Assessing Polyphenolic Content and Antioxidant Activity in Olive Leaves. Foods 2024, 13, 189. [Google Scholar] [CrossRef]
  3. Minelli, P.; Montinari, M.R. The Mediterranean Diet And Cardioprotection: Historical Overview And Current Research. J. Multidiscip. Healthc. 2019, 12, 805–815. [Google Scholar] [CrossRef] [PubMed]
  4. Monteiro, C.S.; Adedara, I.A.; Farombi, E.O.; Emanuelli, T. Nutraceutical potential of olive pomace: Insights from cell-based and clinical studies. J. Sci. Food Agric. 2024. [Google Scholar] [CrossRef] [PubMed]
  5. Garcia-Aloy, M.; Groff, N.; Masuero, D.; Nisi, M.; Franco, A.; Battelini, F.; Vrhovsek, U.; Mattivi, F. Exploratory Analysis of Commercial Olive-Based Dietary Supplements Using Untargeted and Targeted Metabolomics. Metabolites 2020, 10, 516. [Google Scholar] [CrossRef] [PubMed]
  6. Rivas-Garcia, L.; Navarro-Hortal, M.D.; Romero-Marquez, J.M.; Llopis, J.; Forbes-Hernández T., Y.; Xiao, J.; Quiles, J.L.; Sanchez-Gonzalez, C. Valorization of Olea europaea and olive oil processing by-products/wastes. Adv. Food Nutr. Res. 2023, 107, 193–212. [Google Scholar] [CrossRef] [PubMed]
  7. Chrysant, S.G.; Chrysant, G.S. Olive Oil Consumption and Cardiovascular Protection: Mechanism of Action. Cardiol. Rev. 2024, 32, 57–61. [Google Scholar] [CrossRef] [PubMed]
  8. Reyes-Goya, C.; Santana-Garrido, Á.; Espinosa-Martín, P.; Vázquez, C.M.; Mate, A. Wild and cultivated olive trees: Nutraceutical insights of extra virgin olive oils in cardiovascular and ocular diseases. Biochim. Biophys. Acta Mol. Basis Dis. 2024, 1870, 166904. [Google Scholar] [CrossRef] [PubMed]
  9. Ross F., C.; Mayer D., E.; Horn, J.; Cryan J., F.; Del Rio, D.; Randolph, E.; Gill C. I., R.; Gupta, A.; Ross R., P.; Santon, C.; et al. Potential of dietary polyphenols for protection from age-related decline and neurodegeneration: A role for gut microbiota? Nutr. Neurosci. 2024. [Google Scholar] [CrossRef]
  10. Godny, L.; Dotan, I. Is the Mediterranean Diet in Inflammatory Bowel Diseases Ready for Prime Time? J. Can. Assoc. Gastroenterol. 2024, 7, 97–103. [Google Scholar] [CrossRef]
  11. Luaces, P.; Expósito, J.; Benabal, P.; Pascual, M.; Sanz, C.; Pérez, A.G. Accumulation Patterns of Metabolites Responsible for the Functional Quality of Virgin Olive Oil during Olive Fruit Ontogeny. Antioxidants 2023, 13, 12. [Google Scholar] [CrossRef]
  12. Costa, M.; Costa, V.; Lopes, M.; Paiva-Martins, F. A biochemical perspective on the fate of virgin olive oil phenolic compounds in vivo. Crit. Rev. Food Sci. Nutr. 2024, 64, 1403–1428. [Google Scholar] [CrossRef]
  13. Cardoni, M.; Mercado-Blanco, J. Confronting stresses affecting olive cultivation from the holobiont perspective. Front. Plant Sci. 2023, 14, 1261754. [Google Scholar] [CrossRef] [PubMed]
  14. Arias, N.S.; Scholz, F.G.; Goldstein, G.; Bucci, S.J. Low-temperature acclimation and legacy effects of summer water deficits in olive freezing resistance. Tree Physiol. 2021, 41, 1836–1847. [Google Scholar] [CrossRef] [PubMed]
  15. Alemu, M.; Asfaw, Z.; Lulekal, E.; Warkineh, B.; Debella, A.; Sisay, B.; Debebe, E. Ethnobotanical study of traditional medicinal plants used by the local people in Habru District, North Wollo Zone, Ethiopia. J. Ethnobiol. Ethnomed. 2024, 20, 4. [Google Scholar] [CrossRef] [PubMed]
  16. Klionsky, D.J.; Abdel-Aziz, A.K.; Abdelfatah, S.; Abdellatif, M.; Abdoli, A.; Abel, S.; Abeliovich, H.; Abildgaard, M.A.; Yakubu Y., P.; Acevedo-Arozena, A.; et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy 2021, 17, 1–382. [Google Scholar] [CrossRef] [PubMed]
  17. Lorzadeh, N.; Kazemirad, Y.; Kazemirad, N. Treatment of genital herpes using olive leaf extract. Clin. Case Rep. 2021, 9, 986–989. [Google Scholar] [CrossRef] [PubMed]
  18. Acar-Tek, N.; Ağagündüz, D. Olive Leaf (Olea europaea L. folium): Potential Effects on Glycemia and Lipidemia. Ann. Nutr. Metab. 2020, 76, 10–15. [Google Scholar] [CrossRef]
  19. Álvares, A.A.; Garcêz, A.; Silva, L.T.; Averbuch, N.; Garavaglia, J. Olive leaf extract effect on cardiometabolic risk factors: A systematic review and meta-analysis of randomized clinical trials. Nutr. Rev. 2024, nuad164. [Google Scholar] [CrossRef]
  20. Vijakumaran, U.; Shanmugam, J.; Heng, J.W.; Azman, S.S.; Yazid, M.D.; Haizum Abdullah, N.A.; Sulaiman, N. Effects of Hydroxytyrosol in Endothelial Functioning: A Comprehensive Review. Molecules 2023, 28, 1861. [Google Scholar] [CrossRef]
  21. Ismail, M.A.; Norhayati, M.N.; Mohamad, N. Olive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: A systematic review and meta-analysis. PeerJ 2021, 9, e11173. [Google Scholar] [CrossRef]
  22. Vezza, T.; Rodríguez-Nogales, A.; Algieri, F.; Garrido-Mesa, J.; Romero, M.; Sánchez, M.; Toral, M.; Martín-García, B.; Gómez-Caravaca, A.M.; Arráez-Román, D. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties. Pharmacol. Res. 2019, 150, 104487. [Google Scholar] [CrossRef] [PubMed]
  23. Sánchez-Gutiérrez, M.; Bascón-Villegas, I.; Rodríguez, A.; Pérez-Rodríguez, F.; Fernández-Prior, Á.; Rosal, A.; Carrasco, E. Valorisation of Olea europaea L. Olive Leaves through the Evaluation of Their Extracts: Antioxidant and Antimicrobial Activity. Foods 2021, 10, 966. [Google Scholar] [CrossRef] [PubMed]
  24. Robles-Almazan, M.; Pulido-Moran, M.; Moreno-Fernandez, J.; Ramirez-Tortosa, C.; Rodriguez-Garcia, C.; Quiles, J.L.; Ramirez-Tortosa, M. Hydroxytyrosol: Bioavailability, toxicity, and clinical applications. Food Res. Int. 2018, 105, 654–667. [Google Scholar] [CrossRef] [PubMed]
  25. Difonzo, G.; Squeo, G.; Pasqualone, A.; Summo, C.; Paradiso, V.M.; Caponio, F. The challenge of exploiting polyphenols from olive leaves: Adition to foods to improve their shelf-life and nutritional value. J. Sci. Food Agric. 2021, 101, 3099–3116. [Google Scholar] [CrossRef] [PubMed]
  26. Borjan, D.; Leitgeb, M.; Knez, Ž.; Hrnčič, M.K. Microbiological and Antioxidant Activity of Phenolic Compounds in Olive Leaf Extract. Molecules 2020, 25, 5946. [Google Scholar] [CrossRef] [PubMed]
  27. Almaksour, Z.; Boudard, F.; Kelly, M.T.; Pujalté, I.; Villareal, M.; Isoda, H.; Guzman, C.; Larroque, M.; Margout, D. Varietal Effect on the Concentration and Anti-Inflammatory Activity of Hydroxytyrosol in French Olive Oils. J. Med. Food 2020, 23, 1328–1331. [Google Scholar] [CrossRef] [PubMed]
  28. Pereira, A.P.; Ferreira, I.C.; Marcelino, F.; Valentão, P.; Andrade, P.B.; Seabra, R.; Estevinho, L.; Bento, A.; Pereira, J.A. Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobrançosa) leaves. Molecules 2007, 12, 1153–1162. [Google Scholar] [CrossRef]
  29. Ferreira, D.M.; de Oliveira, N.M.; Chéu, M.H.; Meireles, D.; Lopes, L.; Oliveira, M.B.; Machado, J. Updated Organic Composition and Potential Therapeutic Properties of Different Varieties of Olive Leaves from Olea europaea. Plants 2023, 12, 688. [Google Scholar] [CrossRef]
  30. Khwaldia, K.; Attour, N.; Matthes, J.; Beck, L.; Schmid, M. Olive byproducts and their bioactive compounds as a valuable source for food packaging applications. Compr. Rev. Food Sci. Food Saf. 2022, 21, 1218–1253. [Google Scholar] [CrossRef]
  31. Baccouri, B.; Rajhi, I.; Theresa, S.; Najjar, Y.; Mohamed, S.N.; Willenberg, I. The potential of wild olive leaves (Olea europaea L. subsp. oleaster) addition as a functional additive in olive oil production: The effects on bioactive and nutraceutical compounds using LC–ESI–QTOF/MS. Eur. Food Res. Technol. 2022, 248, 2809–2823. [Google Scholar] [CrossRef]
  32. Horwitz, W.; Latimer, G.W. Official Methods of Analysis of AOAC International, 17th ed.; AOAC International: Gaithersburg, MD, USA, 2000. [Google Scholar]
  33. Horwitz, W.; Latimer, G. AOAC-Association of official analytical chemists. In Official Methods of Analysis of AOAC International, 18th ed.; AOAC International: Gaithersburg, MD, USA, 2005; Volume 45, pp. 75–76. [Google Scholar]
  34. Zhang, D.; Yao, L.; Chang, Y.; Yang, G.; Xue, Z.; Wang, L.; Zheng, Y.; Guo, L. Evaluation and Comparison of Bioactive Constituents of Artemisiae argyi Folium Collected at Different Developmental Stages. J. AOAC Int. 2021, 104, 515–525. [Google Scholar] [CrossRef] [PubMed]
  35. Lees, M.; Sloanestanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [Google Scholar] [CrossRef]
  36. Soares, C.; Sousa, S.; Machado, S.; Vieira, E.; Carvalho, A.P.; Ramalhosa, M.J.; Morais, S.; Correia, M.; Oliva-Teles, T.; Domingues, V.F.; et al. Bioactive lipids of seaweeds from the portuguese north coast: Health benefits versus potential contamination. Foods 2021, 10, 1366. [Google Scholar] [CrossRef] [PubMed]
  37. Soares, C.; Paíga, P.; Marques, M.; Neto, T.; Carvalho, A.P.; Paiva, A.; Simões, P.; Costa, L.; Bernardo, A.; Fernández, N.; et al. Multi-step subcritical water extracts of Fucus vesiculosus L. and codium tomentosum stackhouse: Composition, health-benefits and safety. Processes 2021, 9, 893. [Google Scholar] [CrossRef]
  38. Vaz, M. Azeite de Trás-os-Montes: Influência da Localização do Olival e das Cultivares nas Características dos Azeites; Instituto Piaget: Lisboa, Portugal, 2011. [Google Scholar]
  39. de Oliveira, N.M.; Lopes, L.; Chéu, M.H.; Soares, E.; Meireles, D.; Machado, J. Updated Mineral Composition and Potential Therapeutic Properties of Different Varieties of Olive Leaves from Olea europaea. Plants 2023, 12, 916. [Google Scholar] [CrossRef] [PubMed]
  40. Błaszczyk, J.W. Metabolites of Life: Phosphate. Metabolites 2023, 13, 860. [Google Scholar] [CrossRef] [PubMed]
  41. Skalny, A.V.; Aschner, M.; Silina, E.V.; Stupin, V.A.; Zaitsev, O.N.; Sotnikova, T.I.; Tazina, S.I.; Zhang, F.; Guo, X.; Tinkov, A.A. The Role of Trace Elements and Minerals in Osteoporosis: A Review of Epidemiological and Laboratory Findings. Biomolecules 2023, 13, 1006. [Google Scholar] [CrossRef] [PubMed]
  42. Negru, A.G.; Pastorcici, A.; Crisan, S.; Cismaru, G.; Popescu, F.G.; Luca, C.T. The Role of Hypomagnesemia in Cardiac Arrhythmias: A Clinical Perspective. Biomedicines 2022, 10, 2356. [Google Scholar] [CrossRef]
  43. Gommers, L.M.M.; Hoenderop, J.G.J.; de Baaij, J.H.F. Mechanisms of proton pump inhibitor-induced hypomagnesemia. Acta Physiol. 2022, 235, e13846. [Google Scholar] [CrossRef]
  44. Issler, T.; Sule, K.; Lewrenz, A.-M.; Prenner, E.J. Differential interactions of essential and toxic metal ions with biologically relevant phosphatidic acid and phosphatidylserine membranes. Biometals 2024. [Google Scholar] [CrossRef]
  45. Gioilli, B.D.; Kidane, T.Z.; Fieten, H.; Tellez, M.; Dalphin, M.; Nguyen, A.; Nguyen, K.; Linder, M.C. Secretion and uptake of copper via a small copper carrier in blood fluid. Metallomics 2022, 14, mfac006. [Google Scholar] [CrossRef] [PubMed]
  46. Tsang, T.; Davis, C.I.; Brady, D.C. Copper biology. Curr. Biol. 2021, 31, R421–R427. [Google Scholar] [CrossRef]
  47. Rahidul Hassan, H. A review on different arsenic removal techniques used for decontamination of drinking water. Environ. Pollut. Bioavailab. 2023, 35, 2165964. [Google Scholar] [CrossRef]
  48. Zhang, L.; Yu, X.; Arun, S.M.; Zhou, C. Effect of freeze-thaw pretreatment combined with variable temperature on infrared and convection drying of lotus root. LWT 2022, 154, 112804. Available online: https://www.sciencedirect.com/science/article/pii/S0023643821019575 (accessed on 11 February 2024). [CrossRef]
  49. Nunes, M.A.; Palmeira, J.D.; Melo, D.; Machado, S.; Lobo, J.C.; Costa, A.S.G.; Alves, R.C.; Ferreira, H.; Oliveira, M.B.P.P. Chemical Composition and Antimicrobial Activity of a New Olive Pomace Functional Ingredient. Pharmaceuticals 2021, 14, 913. [Google Scholar] [CrossRef] [PubMed]
  50. Deng, B.; Kong, W.; Suo, H.; Shen, X.; Newton, M.A.; Burkett, W.C.; Zhao, Z.; John, C.; Sun, W.; Zhang, X.; et al. Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer. Cancers 2023, 15, 5407. [Google Scholar] [CrossRef] [PubMed]
  51. Grubić Kezele, T.; Ćurko-Cofek, B. Neuroprotective Panel of Olive Polyphenols: Mechanisms of Action, Anti-Demyelination, and Anti-Stroke Properties. Nutrients 2022, 14, 4533. [Google Scholar] [CrossRef]
  52. Ascoli Bartoli, T.; Lepore, L.; D’Abramo, A.; Adamo, G.; Corpolongo, A.; Scorzolini, L.; Giancola, M.L.; Bevilacqua, N.; Palazzolo, C.; Mariano, A. Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis. Malar. J. 2021, 20, 206. [Google Scholar] [CrossRef]
  53. Hadrich, F.; Mahmoudi, A.; Chamkha, M.; Isoda, H.; Sayadi, S. Olive Leaves Extract and Oleuropein Improve Insulin Sensitivity in 3T3-L1 Cells and in High-Fat Diet-Treated Rats via PI3K/AkT Signaling Pathway. Oxidative Med. Cell. Longev. 2023, 2023, 6828230. [Google Scholar] [CrossRef]
  54. Subias-Gusils, A.; Álvarez-Monell, A.; Boqué, N.; Caimari, A.; Mariné-Casadó, R.; Escorihuela, R.M.; Solanas, M. Effects of a Calorie-Restricted Cafeteria Diet and Oleuropein Supplementation on Adiposity and mRNA Expression of Energy Balance Related Genes in Obese Male Rats. Metabolites 2023, 13, 147. [Google Scholar] [CrossRef]
  55. Zupo, R.; Castellana, F.; Crupi, P.; Desantis, A.; Rondanelli, M.; Corbo, F.; Clodoveo, M.L. Olive Oil Polyphenols Improve HDL Cholesterol and Promote Maintenance of Lipid Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Metabolites 2023, 13, 1187. [Google Scholar] [CrossRef]
  56. Subias-Gusils, A.; Álvarez-Monell, A.; Boqué, N.; Caimari, A.; Del Bas, J.M.; Mariné-Casadó, R.; Solanas, M.; Escorihuela, R.M. Behavioral and Metabolic Effects of a Calorie-Restricted Cafeteria Diet and Oleuropein Supplementation in Obese Male Rats. Nutrients 2021, 13, 4474. [Google Scholar] [CrossRef]
  57. Antonopoulou, S.; Demopoulos, C.A. Protective Effect of Olive Oil Microconstituents in Atherosclerosis: Emphasis on PAF Implicated Atherosclerosis Theory. Biomolecules 2023, 13, 700. [Google Scholar] [CrossRef]
  58. Gavahian, M.; Mousavi Khaneghah, A.; Lorenzo, J.M.; Munekata, P.E.S.; Garcia-Mantrana, I.; Collado, M.C.; Meléndez-Martínez, A.J.; Barba, F.J. Health benefits of olive oil and its components: Impacts on gut microbiota antioxidant activities, and prevention of noncommunicable diseases. Trends Food Sci. Technol. 2019, 88, 220–227. [Google Scholar] [CrossRef]
  59. Wasner, H.K. Metformin’s Mechanism of Action Is Stimulation of the Biosynthesis of the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP). Int. J. Mol. Sci. 2022, 23, 2200. [Google Scholar] [CrossRef] [PubMed]
  60. Love, K.M.; Barrett, E.J.; Horton, W.B. Metformin’s Impact on the Microvascular Response to Insulin. Endocrinology 2022, 163, bqac162. [Google Scholar] [CrossRef]
  61. Bertelli, M.; Kiani, A.K.; Paolacci, S.; Manara, E.; Kurti, D.; Dhuli, K.; Bushati, V.; Miertus, J.; Pangallo, D.; Baglivo, M.; et al. Hydroxytyrosol: A natural compound with promising pharmacological activities. J. Biotechnol. 2020, 309, 29–33. [Google Scholar] [CrossRef]
  62. Munekata, P.E.S.; Nieto, G.; Pateiro, M.; Lorenzo, J.M. Phenolic Compounds Obtained from Olea europaea By-Products and their Use to Improve the Quality and Shelf Life of Meat and Meat Products-A Review. Antioxidants 2020, 9, 1061. [Google Scholar] [CrossRef]
  63. Zoubdane, N.; Abdo, R.A.; Nguyen, M.; Bentourkia, M.; Turcotte, E.E.; Berrougui, H.; Fulop, T.; Khalil, A. High Tyrosol and Hydroxytyrosol Intake Reduces Arterial Inflammation and Atherosclerotic Lesion Microcalcification in Healthy Older Populations. Antioxidants 2024, 13, 130. [Google Scholar] [CrossRef]
  64. Quirós-Fernández, R.; López-Plaza, B.; Bermejo, L.M.; Palma-Milla, S.; Gómez-Candela, C. Supplementation with Hydroxytyrosol and Punicalagin Improves Early Atherosclerosis Markers Involved in the Asymptomatic Phase of Atherosclerosis in the Adult Population: A Randomized, Placebo-Controlled, Crossover Trial. Nutrients 2019, 11, 640. [Google Scholar] [CrossRef]
  65. Kumar, N.; Gorai, B.; Gupta, S.; Shiva; Goel, N. Extrapolation of hydroxytyrosol and its analogues as potential anti-inflammatory agents. J. Biomol. Struct. Dyn. 2021, 39, 5588–5599. [Google Scholar] [CrossRef]
  66. Arismendi Sosa, A.C.; Mariani, M.L.; Vega, A.E.; Penissi, A.B. Extra virgin olive oil inhibits Helicobacter pylori growth in vitro and the development of mice gastric mucosa lesions in vivo. Front. Microbiol. 2022, 13, 961597. [Google Scholar] [CrossRef]
  67. Gulcin, İ. Antioxidants and antioxidant methods: An updated overview. Arch. Toxicol. 2020, 94, 651–715. [Google Scholar] [CrossRef]
  68. de Carvalho, A.G.A.; Olmo-García, L.; Gaspar, B.R.A.; Carrasco-Pancorbo, A.; Castelo-Branco, V.N.; Torres, A.G. Evaluating Quality Parameters, the Metabolic Profile, and Other Typical Features of Selected Commercial Extra Virgin Olive Oils from Brazil. Molecules 2020, 25, 4193. [Google Scholar] [CrossRef]
  69. Martins, B.T.; Bronze, M.R.; Ventura, M.R. Phenolic Compounds from Virgin Olive Oil: Approaches for Their Synthesis and Analogues. J. Agric. Food Chem. 2022, 70, 14109–14128. [Google Scholar] [CrossRef]
  70. Guo, L.; Gong, S.; Wang, Y.; Sun, Q.; Duo, K.; Fei, P. Antibacterial Activity of Olive Oil Polyphenol Extract Against Salmonella Typhimurium and Staphylococcus aureus: Possible Mechanisms. Foodborne Pathog. Dis. 2020, 17, 396–403. [Google Scholar] [CrossRef]
  71. Ramata-Stunda, A.; Petriņa, Z.; Valkovska, V.; Borodušķis, M.; Gibnere, L.; Gurkovska, E.; Nikolajeva, V. Synergistic Effect of Polyphenol-Rich Complex of Plant and Green Propolis Extracts with Antibiotics against Respiratory Infections Causing Bacteria. Antibiotics 2022, 11, 160. [Google Scholar] [CrossRef]
  72. Nazzaro, F.; Fratianni, F.; Cozzolino, R.; Martignetti, A.; Malorni, L.; De Feo, V.; Cruz, A.G.; d’Acierno, A. Antibacterial activity of three extra virgin olive oils of the Campania region, Southern Italy, related to their polyphenol content and composition. Microorganisms 2019, 7, 321. [Google Scholar] [CrossRef]
  73. Liu, Y.; McKeever, L.C.; Malik, N.S.A. Assessment of the Antimicrobial Activity of Olive Leaf Extract Against Foodborne Bacterial Pathogens. Front. Microbiol. 2017, 8, 113. [Google Scholar] [CrossRef]
  74. Alkhatib, A. Antiviral Functional Foods and Exercise Lifestyle Prevention of Coronavirus. Nutrients 2020, 12, 2633. [Google Scholar] [CrossRef]
  75. Somerville, V.; Moore, R.; Braakhuis, A. The effect of olive leaf extract on upper respiratory illness in high school athletes: A randomised control trial. Nutrients 2019, 11, 358. [Google Scholar] [CrossRef]
  76. de Oliveira, J.R.; Antunes, B.S.; do Nascimento, G.O.; de Kawall, J.C.S.; Oliveira, J.V.B.; Silva, K.G.D.S.; Costa, M.A.T.; Oliveira, C.R. Antiviral activity of medicinal plant-derived products against SARS-CoV-2. Exp. Biol. Med. 2022, 247, 1797–1809. [Google Scholar] [CrossRef]
  77. Yang, X.; Yan, T.; Shen, D.; Sheng, M.; Huang, W.; Li, L.; Chai, D. Prognostic Value of Wagner Grade and Platelet Level in Diabetics with Infected Foot Ulcers After Antibiotic Therapy. Infect. Drug Resist. 2023, 16, 7435–7445. [Google Scholar] [CrossRef]
  78. Zhang, J.; Chen, L.; Yang, Y.; Liu, X.; Yuan, Y.; Song, S.-R.; Zhao, Y.; Mao, J. Clinical and laboratory findings to differentiate late-onset sepsis caused by Gram-negative vs Gram-positive bacteria among perterm neonates: A retrospective cohort study. Int. Immunopharmacol. 2023, 116, 109769. [Google Scholar] [CrossRef]
  79. Sizar, O.; Leslie, S.W.; Unakal, C.G. Gram-Positive Bacteria. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK470553/ (accessed on 10 February 2024).
  80. Macdonald, K.E.; Boeckh, S.; Stacey, H.J.; Jones, J.D. The microbiology of diabetic foot infections: A meta-analysis. BMC Infect. Dis. 2021, 21, 770. [Google Scholar] [CrossRef]
  81. Song, Y.; Yang, F.; Mu, B.; Kang, Y.; Hui, A.; Wang, A. Phyto-mediated synthesis of Ag nanoparticles/attapulgite nanocomposites using olive leaf extract: Characterization, antibacterial activities and cytotoxicity. Inorg. Chem. Commun. 2023, 151, 110543. [Google Scholar] [CrossRef]
  82. Alowaiesh, B.F.; Alhaithloul, H.A.; Saad, A.M.; Hassanin, A.A. Green Biogenic of Silver Nanoparticles Using Polyphenolic Extract of Olive Leaf Wastes with Focus on Their Anticancer and Antimicrobial Activities. Plants 2023, 12, 1410. [Google Scholar] [CrossRef]
  83. Bouallagui, Z.; Mahmoudi, A.; Maalej, A.; Hadrich, F.; Isoda, H.; Sayadi, S. Contribution of Major Polyphenols to the Antioxidant Profile and Cytotoxic Activity of Olive Leaves. Anticancer Agents Med. Chem. 2019, 19, 1651–1657. [Google Scholar] [CrossRef]
  84. Mushtaq, Z.; Sadeer, N.B.; Hussain, M.; Mahwish; Alsagaby, S.A.; Imran, M.; Mumtaz, T.; Umar, M.; Tauseef, A.; Al Abdulmonem, W.; et al. Therapeutical properties of apigenin: A review on the experimental evidence and basic mechanisms. Int. J. Food Prop. 2023, 26, 1914–1939. [Google Scholar] [CrossRef]
  85. Niu, C.; Zhang, J.; Okolo, P. Greasing the Wheels of Pharmacotherapy for Colorectal Cancer: The Role of Natural Polyphenols. Curr. Nutr. Rep. 2023, 12, 662–678. [Google Scholar] [CrossRef]
  86. Caporali, S.; De Stefano, A.; Calabrese, C.; Giovannelli, A.; Pieri, M.; Savini, I.; Tesauro, M.; Bernardini, S.; Minieri, M.; Terrinoni, A. Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside. Nutrients 2022, 14, 1155. [Google Scholar] [CrossRef]
  87. Xi, M.; Hou, Y.; Wang, R.; Ji, M.; Cai, Y.; Ao, J.; Shen, H.; Li, M.; Wang, J.; Luo, A. Potential Application of Luteolin as an Active Antibacterial Composition in the Development of Hand Sanitizer Products. Molecules 2022, 27, 7342. [Google Scholar] [CrossRef]
  88. Qian, W.; Liu, M.; Fu, Y.; Zhang, J.; Liu, W.; Li, J.; Li, X.; Li, Y. Antimicrobial mechanism of luteolin against Staphylococcus aureus and Listeria monocytogenes and its antibiofilm properties. Microb. Pathog. 2020, 142, 104056. [Google Scholar] [CrossRef]
  89. Sezen Karaoğlan, E.; Hancı, H.; Koca, M.; Kazaz, C. Some Bioactivities of Isolated Apigenin-7-O-glucoside and Luteolin-7-O-glucoside. Appl. Sci. 2023, 13, 1503. [Google Scholar] [CrossRef]
  90. Kubica, P.; Szopa, A.; Kokotkiewicz, A.; Miceli, N.; Taviano, M.F.; Maugeri, A.; Cirmi, S.; Synowiec, A.; Gniewosz, M.; Elansary, H.O.; et al. Production of Verbascoside, Isoverbascoside and Phenolic Acids in Callus, Suspension, and Bioreactor Cultures of Verbena officinalis and Biological Properties of Biomass Extracts. Molecules 2020, 25, 5609. [Google Scholar] [CrossRef]
  91. Shi, C.; Ma, Y.; Tian, L.; Li, J.; Qiao, G.; Liu, C.; Cao, W.; Liang, C. Verbascoside: An Efficient and Safe Natural Antibacterial Adjuvant for Preventing Bacterial Contamination of Fresh Meat. Molecules 2022, 27, 4943. [Google Scholar] [CrossRef]
  92. Nani, A.; Murtaza, B.; Sayed Khan, A.; Khan, N.A.; Hichami, A. Antioxidant and Anti-Inflammatory Potential of Polyphenols Contained in Mediterranean Diet in Obesity: Molecular Mechanisms. Molecules 2021, 26, 985. [Google Scholar] [CrossRef]
  93. Bermúdez-Oria, A.; Bouchal, Y.; Fernández-Prior, Á.; Vioque, B.; Fernández-Bolaños, J. Strawberry Puree Functionalized with Natural Hydroxytyrosol: Effects on Vitamin C and Antioxidant Activity. Molecules 2020, 25, 5829. [Google Scholar] [CrossRef]
  94. Šimat, V.; Skroza, D.; Tabanelli, G.; Čagalj, M.; Pasini, F.; Gómez-Caravaca, A.M.; Fernández-Fernández, C.; Sterniša, M.; Smole Možina, S.; Ozogul, Y.; et al. Antioxidant and Antimicrobial Activity of Hydroethanolic Leaf Extracts from Six Mediterranean Olive Cultivars. Antioxidants 2022, 11, 1656. [Google Scholar] [CrossRef]
  95. Rana, S.S.; Tiwari, S.; Gupta, N.; Tripathi, M.K.; Tripathi, N.; Singh, S.; Bhagyawant, S.S. Validating the Nutraceutical Significance of Minor Millets by mploying Nutritional-Antinutritional Profiling. Life 2023, 13, 1918. [Google Scholar] [CrossRef]
  96. C de S Ribeiro, B.; V de C Faria, R.; de S Nogueira, J.; Santos Valença, S.; Chen, L.; Romana-Souza, B. Olive oil promotes the survival and migration of dermal fibroblasts through Nrf2 pathway activation. Lipids 2023, 58, 59–68. [Google Scholar] [CrossRef] [PubMed]
  97. Del Saz-Lara, A.; López de Las Hazas, M.-C.; Visioli, F.; Dávalos, A. Nutri-Epigenetic Effects of Phenolic Compounds from Extra Virgin Olive Oil: A Systematic Review. Adv. Nutr. 2022, 13, 2039–2060. [Google Scholar] [CrossRef]
  98. Serreli, G.; Melis, M.P.; Corona, G.; Deiana, M. Modulation of LPS-induced nitric oxide production in intestinal cells by hydroxytyrosol and tyrosol metabolites: Insight into the mechanism of action. Food Chem. Toxicol. 2019, 125, 520–527. [Google Scholar] [CrossRef]
  99. De Cicco, P.; Ercolano, G.; Tenore, G.C.; Ianaro, A. Olive leaf extract inhibits metastatic melanoma spread through suppression of epithelial to mesenchymal transition. Phytother. Res. 2022, 36, 4002–4013. [Google Scholar] [CrossRef] [PubMed]
  100. Infante, R.; Infante, M.; Pastore, D.; Pacifici, F.; Chiereghin, F.; Malatesta, G.; Donadel, G.; Tesauro, M.; Della-Morte, D. An Appraisal of the Oleocanthal-Rich Extra Virgin Olive Oil (EVOO) and Its Potential Anticancer and Neuroprotective Properties. Int. J. Mol. Sci. 2023, 24, 17323. [Google Scholar] [CrossRef]
  101. Antoniou, C.; Hull, J. The Anti-cancer Effect of Olea europaea L. Products: A Review. Curr. Nutr. Rep. 2021, 10, 99–124. [Google Scholar] [CrossRef]
  102. de Aguiar Sobral, P.; Miyahira, R.F.; Zago, L. Health Outcomes Related to the Consumption of Olive Products: A Brief Review. Plant Foods Hum. Nutr. 2023, 78, 643–653. [Google Scholar] [CrossRef]
  103. Pannucci, E.; Caracciolo, R.; Romani, A.; Cacciola, F.; Dugo, P.; Bernini, R.; Varbaro, L.; Santi, L. ; An hydroxytyrosol enriched extract from olive mill wastewaters exerts antioxidant activity and antimicrobial activity on Pseudomonas savastanoi pv. savastanoi and Agrobacterium tumefaciens. Nat. Prod. Res. 2021, 35, 2677–2684. [Google Scholar] [CrossRef]
  104. Ferreira, D.M.; de Oliveira, N.M.; Lopes, L.; Machado, J.; Oliveira, M.B. Potential Therapeutic Properties of the Leaf of Cydonia Oblonga Mill. Based on Mineral and Organic Profiles. Plants 2022, 11, 2638. [Google Scholar] [CrossRef]
  105. Szewczyk, K.; Chojnacka, A.; Górnicka, M. Tocopherols and Tocotrienols-Bioactive Dietary Compounds; What Is Certain, What Is Doubt? Int. J. Mol. Sci. 2021, 22, 6222. [Google Scholar] [CrossRef]
  106. Fu, J.-Y.; Meganathan, P.; Gunasegaran, N.; Tan, D.M.Y. Effect of nano-delivery systems on the bioavailability and tissue biodistribution of vitamin E tocotrienols. Food Res. Int. 2023, 171, 113048. [Google Scholar] [CrossRef]
  107. Tarchoune, I.; Sgherri, C.; Eddouzi, J.; Zinnai, A.; Quartacci, M.F.; Zarrouk, M. Olive Leaf Addition Increases Olive Oil Nutraceutical Properties. Molecules 2019, 24, 545. [Google Scholar] [CrossRef]
  108. Zhou, S.; Huang, G. The biological activities of butyrylcholinesterase inhibitors. Biomed. Pharmacother. 2022, 146, 112556. [Google Scholar] [CrossRef]
  109. Mathew, B.; Parambi, D.G.T.; Mathew, G.E.; Uddin, M.S.; Inasu, S.T.; Kim, H.; Marathakam, A.; Unnikrishnan, M.K.; Carradori, S. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer’s and Parkinson’s diseases. Arch. Pharm. 2019, 352, e1900177. [Google Scholar] [CrossRef]
  110. Abdellaoui, K.; Boussadia, O.; Miladi, M.; Boughattas, I.; Omri, G.; Mhafdhi, M.; Hazzoug, M.; Acheuk, F.; Brahem, M. Olive Leaf Extracts Toxicity to the Migratory Locust, Locusta migratoria: Histopathological Effects on the Alimentary Canal and Acetylcholinesterase and Glutathione S-Transferases Activity. Neotrop. Entomol. 2019, 48, 246–259. [Google Scholar] [CrossRef]
  111. Gulcan, H.O.; Orhan, I.E. A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010–2019. Comb. Chem. High Throughput Screen. 2020, 23, 862–876. [Google Scholar] [CrossRef]
  112. Mathew, B.; Kim, H. Inhibitors of Monoamine Oxidase and Acetylcholinesterase as a Front Runner in CNS Drug Discovery. Comb. Chem. High Throughput Screen. 2020, 23, 834–835. [Google Scholar] [CrossRef]
  113. Chaurasiya, N.D.; Leon, F.; Muhammad, I.; Tekwani, B.L. Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma. Molecules 2022, 27, 4297. [Google Scholar] [CrossRef]
  114. Garjón, J.; Saiz, L.C.; Azparren, A.; Gaminde, I.; Ariz, M.J.; Erviti, J. First-line combination therapy versus first-line monotherapy for primary hypertension. Cochrane Database Syst Rev. 2020, 2, CD010316. [Google Scholar] [CrossRef]
  115. Ajebli, M.; Eddouks, M. Phytotherapy of Hypertension: An Updated Overview. Endocr. Metab. Immune Disord. Drug Targets 2020, 20, 812–839. [Google Scholar] [CrossRef]
  116. Saad, B. A Review of the Anti-Obesity Effects of Wild Edible Plants in the Mediterranean Diet and Their Active Compounds: From Traditional Uses to Action Mechanisms and Therapeutic Targets. Int. J. Mol. Sci. 2023, 24, 12641. [Google Scholar] [CrossRef]
  117. Chukwuma, C.I.; Matsabisa, M.G.; Ibrahim, M.A.; Erukainure, O.L.; Chabalala, M.H.; Islam, M.S. Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension: A review. J. Ethnopharmacol. 2019, 235, 329–360. [Google Scholar] [CrossRef]
  118. Susalit, E.; Agus, N.; Effendi, I.; Tjandrawinata, R.R.; Nofiarny, D.; Perrinjaquet-Moccetti, T.; Verbruggen, M. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with Captopril. Phytomedicine 2011, 18, 251–258. [Google Scholar] [CrossRef]
  119. Barroso, M.F.; Ramalhosa, M.J.; Alves, R.C.; Dias, A.; Soares, C.M.D.; Oliva-Teles, M.T.; Delerue-Matos, C. Total antioxidant capacity of plant infusions: Assessment using electrochemical DNA-based biosensor and spectrophotometric methods. Food Control. 2016, 68, 153–161. [Google Scholar] [CrossRef]
  120. Benichou, T.; Pereira, B.; Mermillod, M.; Tauveron, I.; Pfabigan, D.; Maqdasy, S.; Dutheil, F. Heart rate variability in type 2 diabetes mellitus: A systematic review and meta-analysis. PLoS ONE 2018, 13, e0195166. [Google Scholar] [CrossRef] [PubMed]
  121. Bondia-Pons, I.; Molto-Puigmarti, C.; Castellote, A.I.; Lopez-Sabater, M.C. Determination of conjugated linoleic acid in human plasma by fast gas chromatography. J. Chromatogr. A 2007, 1157, 422–429. [Google Scholar] [CrossRef] [PubMed]
  122. Guerreiro, I.; Magalhães, R.; Coutinho, F.; Couto, A.; Sousa, S.; Delerue-Matos, C.; Domingues, V.F.; Oliva-Teles, A.; Peres, H. Evaluation of the seaweeds Chondrus crispus and Ulva lactuca as functional ingredients in gilthead seabream (Sparus aurata). J. Appl. Phycol. 2019, 31, 2115–2124. [Google Scholar] [CrossRef]
  123. Vuletin Selak, G.; Baruca Arbeiter, A.; Cuevas, J.; Perica, S.; Pujic, P.; Raboteg Božiković, M.; Bandelj, D. Seed Paternity Analysis Using SSR Markers to Assess Successful Pollen Donors in Mixed Olive Orchards. Plants 2021, 10, 2356. [Google Scholar] [CrossRef] [PubMed]
Figure 1. NO scavenging activity of O. europaea leaf extracts. Three assays were performed (n = 3). For each tested concentration, different lowercase letters mean statistically significant differences at p < 0.05.
Figure 1. NO scavenging activity of O. europaea leaf extracts. Three assays were performed (n = 3). For each tested concentration, different lowercase letters mean statistically significant differences at p < 0.05.
Pharmaceuticals 17 00274 g001
Figure 2. HPLC-FLD of hydroethanolic extracts of O. europaea leaves ((A)—O. europaea Cobrançosa; (B)—O. europaea Madural; (C)—O. europaea Verdeal; 8—α-tocopherol; 9—δ-tocopherol; 10 + 11—γ- and β-tocopherols).
Figure 2. HPLC-FLD of hydroethanolic extracts of O. europaea leaves ((A)—O. europaea Cobrançosa; (B)—O. europaea Madural; (C)—O. europaea Verdeal; 8—α-tocopherol; 9—δ-tocopherol; 10 + 11—γ- and β-tocopherols).
Pharmaceuticals 17 00274 g002
Figure 3. Acetylcholinesterase (AChE) (A) and butyrylcholinesterase (BuChE) (B) inhibition by extracts of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal. Three assays were performed (n = 3). For each concentration tested, different lowercase letters mean statistically significant differences at p < 0.05.
Figure 3. Acetylcholinesterase (AChE) (A) and butyrylcholinesterase (BuChE) (B) inhibition by extracts of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal. Three assays were performed (n = 3). For each concentration tested, different lowercase letters mean statistically significant differences at p < 0.05.
Pharmaceuticals 17 00274 g003
Figure 4. Monoamine oxidase A (MAO-A) (A) and B (MAO-B) (B) inhibition by extracts of O. europaea leaves. In total, three assays were performed (n = 3). For each tested concentration, different lowercase letters mean statistically significant differences at p < 0.05.
Figure 4. Monoamine oxidase A (MAO-A) (A) and B (MAO-B) (B) inhibition by extracts of O. europaea leaves. In total, three assays were performed (n = 3). For each tested concentration, different lowercase letters mean statistically significant differences at p < 0.05.
Pharmaceuticals 17 00274 g004
Figure 5. Angiotensin-converting enzyme (ACE) (A) and renin (B) inhibition by leaf extracts of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal. In total, three assays were performed (n = 3). For each tested concentration, different lowercase letters mean statistically significant differences at p < 0.05.
Figure 5. Angiotensin-converting enzyme (ACE) (A) and renin (B) inhibition by leaf extracts of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal. In total, three assays were performed (n = 3). For each tested concentration, different lowercase letters mean statistically significant differences at p < 0.05.
Pharmaceuticals 17 00274 g005
Figure 6. (A) Olive tree of O. europaea Madural. (B) Fruits and leaves of O. europaea Madural. Photos taken from the olive grove in Vale de Salgueiros, Mirandela, in May 2022.
Figure 6. (A) Olive tree of O. europaea Madural. (B) Fruits and leaves of O. europaea Madural. Photos taken from the olive grove in Vale de Salgueiros, Mirandela, in May 2022.
Pharmaceuticals 17 00274 g006
Figure 7. (A) Olive tree of O. europaea Cobrançosa. (B) Fruits and leaves of O. europaea Cobrançosa. Photos taken from the olive grove in Vale de Salgueiros, Mirandela, in May 2022.
Figure 7. (A) Olive tree of O. europaea Cobrançosa. (B) Fruits and leaves of O. europaea Cobrançosa. Photos taken from the olive grove in Vale de Salgueiros, Mirandela, in May 2022.
Pharmaceuticals 17 00274 g007
Figure 8. (A) Olive tree of O. europaea Verdeal. (B) Fruits and leaves of O. europaea Verdeal. Photos taken from the olive grove in Vale de Salgueiros, Mirandela, in May 2022.
Figure 8. (A) Olive tree of O. europaea Verdeal. (B) Fruits and leaves of O. europaea Verdeal. Photos taken from the olive grove in Vale de Salgueiros, Mirandela, in May 2022.
Pharmaceuticals 17 00274 g008
Table 1. Mineral analysis of leaf samples of O. europaea. Study conducted with leaves extracted from three varieties of olive tree: O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal cultivars. These cultivars grew up randomly distributed in the same geographical area of Vale de Salgueiros in the Mirandela region of the North of Portugal.
Table 1. Mineral analysis of leaf samples of O. europaea. Study conducted with leaves extracted from three varieties of olive tree: O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal cultivars. These cultivars grew up randomly distributed in the same geographical area of Vale de Salgueiros in the Mirandela region of the North of Portugal.
CultivarUnitsO. europaea CobrançosaO. europaea MaduralO. europaea VerdealDRIs—Male
(31–50 y.o.) **
Elements
Asmg/kg<3.0 ± 0.03<3.0± 0.037 ± 0.03N/A
Bamg/kg18 ± 0.0513 ± 0.0512 ± 0.05N/A
Cag/Kg11 ± 0.0512 ± 0.0511 ± 0.051.00 g/d
Cdmg/kg<0.25<0.25<0.25N/A
Crmg/kg0.65 ± 0.03<0.50.72 ± 0.0335 mg/d
Cumg/kg12 ± 0.055.6 ± 0.036.5 ± 0.030.90 mg/d
Femg/kg104 ± 0.0591 ± 0.0582 ± 0.058 mg/d
Kg/Kg9.2 ± 0.037.1 ± 0.0313 ± 0.053.40 g/d
Mgg/Kg1.2 ± 0.031.7 ± 0.031.4 ± 0.030.42 g/d
Mnmg/kg47 ± 0.0546 ± 0.0556 ± 0.052.3 mg/d
Nag/Kg0.05 ± 0.030.04 ± 0.030.07 ± 0.031.5 g/d
Pbmg/kg<2.5<2.5<2.5N/A
Semg/kg<2.5<2.5<2.50.055 mg/d
Srmg/kg95 ± 0.05101 ± 0.05103 ± 0.0514.0 mg/d
Znmg/kg12 ± 0.0517 ± 0.0517 ± 0.0511.0 mg/d
Momg/kg<3.0<3.0<3.00.045 mg/d
Sg/Kg2.2 ± 0.030.37 ± 0.031.5 ± 0.03N/A
Pg/Kg1.3 ± 0.031.5 ± 0.031.5 ± 0.030.70 g/d
** DRIs (daily recommended intakes)—https://nap.nationalacademies.org/read/11537/chapter/59#536 (accessed on 7 December 2023).
Table 2. Proximate composition, total phenolic content (TPC), and total flavonoid content (TFC) of O. europaea leaf extracts.
Table 2. Proximate composition, total phenolic content (TPC), and total flavonoid content (TFC) of O. europaea leaf extracts.
ComponentAsh
(%)
Lipid
(%)
Protein
(%)
Water
(%)
TPC (mgGAE/g Sample)TFC (mgECE/g Sample)
Cultivar
O. europaea Cobrançosa4.34 ± 0.30 a5.03 ± 0.04 a6.15 ± 0.12 b8.86 ± 0.15 a37.90 ± 4.20 c30.40 ± 0.80 b
O. europaea Madural4.42 ± 0.14 a4.50 ± 0.30 a6.43 ± 0.09 a8.70 ± 0.17 a,b48.90 ± 2.40 b29.10 ± 0.50 b
O. europaea Verdeal4.79 ± 0.04 a4.80 ± 0.50 a3.81 ± 0.02 c8.20 ± 0.35 b59.30 ± 4.30 a53.70 ± 5.20 a
GAE—gallic acid equivalent; ECE—epicatechin equivalent. Results are expressed as mean ± standard deviation of three determinations (n = 3). For each column/row, different superscript letters mean statistically significant differences at p < 0.05.
Table 3. Phenolic composition of the hydroethanolic extracts of the selected O. europaea leaves.
Table 3. Phenolic composition of the hydroethanolic extracts of the selected O. europaea leaves.
ParameterRT (min)ʎmax (nm)Cultivar (mg/g Dried Extract)
Compounds O. europaea CobrançosaO. europaea MaduralO. europaea Verdeal
Hydroxytyrosol9.702767.78 ± 2.00 a10.86 ± 0.88 a10.64 ± 0.15 a
Tyrosol12.502800.13 ± 0.04 b0.27 ± 0.05 a0.20 ± <0.01 a,b
Caffeic acid18.26250, 290sh, 3230.19 ± 0.03 a0.20 ± 0.01 a0.21 ± 0.03 a
Verbascoside32.23253, 296sh, 3312.30 ± 0.16 a2.31 ± 0.04 a2.40 ± 0.43 a
Luteolin-7-O-glucoside42.44257, 267sh, 3482.72 ± 0.01 b4.27 ± <0.01 a2.69 ± 0.03 b
Apigenin-7-O-glucoside46.07267, 3362.91 ± 0.07 b3.82 ± 0.22 a2.01 ± 0.09 c
Apigenin derivative48.60268, 3385.03 ± 0.11 b6.32 ± 0.29 a4.92 ± 0.10 b
Total 21.0628.0523.07
ab Results are expressed as mean ± standard deviation for three assessments (n = 3). For each row, different superscript letters mean statistically significant differences at p < 0.05.
Table 4. Fatty acid composition (values expressed as % fatty acid ± SD).
Table 4. Fatty acid composition (values expressed as % fatty acid ± SD).
CultivarsO. europaea CobrançosaO. europaea MaduralO. europaea Verdeal
FAs
SFA
C4:0---
C6:0---
C8:0---
C10:0---
C11:0---
C12:00.347% ± 0.007%0.28% ± 0.02%0.24% ± 0.01%
C13:0---
C14:02.48% ± 0.07%1.94% ± 0.05%2.85% ± 0.06%
C15:00.24% ± 0.01%0.308% ± 0.006%0.27% ± 0.01%
C16:033.6% ± 0.1%31.3% ± 0.2%30.9% ± 0.6%
C17:00.57% ± 0.03%0.36% ± 0.02%0.49% ± 0.02%
C18:08.15% ± 0.03%8.8% ± 0.6%7.0% ± 0.2%
C20:0---
C21:00.34% ± 0.02%0.47% ± 0.02%0.53% ± 0.02%
C22:0---
C23:00.51% ± 0.04%0.80% ± 0.04%0.38% ± 0.02%
C24:02.4% ± 0.2%3.3% ± 0.3%3.04% ± 0.03%
MUFA
C14:1 n-5---
C15:1 n-5---
C16:1 n-71.18% ± 0.02%0.57% ± 0.03%0.48% ± 0.01%
C17:1 n-7---
C18:1 n-9 t---
C18:1 n-9 c25.49% ± 0.09%19.7% ± 0.3%21.7% ± 0.2%
C20:1n-913.3% ± 0.1%17.6% ± 0.2%17.6% ± 0.2%
C22:1 n-9---
C24:1 n-9---
PUFA
C18:2 n-6 t---
C18:2 n-6 c6.05% ± 0.04%8.5% ± 0.2%8.0% ± 0.1%
C18:3 n-30.52% ± 0.02%0.622% ± 0.005%0.71% ± 0.04%
C18:3 n-62.93% ± 0.03%3.8% ± 0.1%3.19% ± 0.10%
C20:2 n-6---
C20:3 n-3---
C20:3 n-62.01% ± 0.04%2.3% ± 0.2%2.3% ± 0.1%
C20:4 n-6---
C20:5 n-3---
C22:2 n-6---
C22:6 n-3-0.44% ± 0.02%0.40% ± 0.02%
ΣSFA48.6%46.71%45.75%
ΣMUFA39.9%37.87%39.74%
ΣPUFA11.5%15.42%14.51%
Σω30.5%0.84%1.10%
Σω611.0%14.58%13.41%
Table 5. Antioxidant activity of hydroethanolic extracts of O. europaea leaves.
Table 5. Antioxidant activity of hydroethanolic extracts of O. europaea leaves.
Antioxidant Activity DPPH-RSA (ug/mL) FRAP (mg AAE/g Sample) NO (IC50, µg/mL)
Cultivar
O. europaea Cobrançosa685.2 ±34.4 b16.6 ± 0.5 b>2000
(32.2% inhibition at 2000 µg/mL)
O. europaea Madural490.8 ± 24.5 a19.1 ± 0.6 a>2000
(24.8% inhibition at 2000 µg/mL)
O. europaea Verdeal217.2 ± 10.9 a17.0 ± 0.01 b>2000
(47.3% inhibition at 2000 µg/mL)
RSA—radical scavenging activity; FRAP—ferric reducing antioxidant power assay; TE—Trolox equivalent; AAE—ascorbic acid equivalent. Results are expressed as mean ± standard deviation of three determinations (n = 3). For each column, different superscript letters mean statistically significant differences at p < 0.05.
Table 6. Antimicrobial activity of Olea europaea extracts at 20 mg/mL, positive control (lactic acid), and negative control (DMSO).
Table 6. Antimicrobial activity of Olea europaea extracts at 20 mg/mL, positive control (lactic acid), and negative control (DMSO).
CULTIVARInhibition Zone (mm)
Gram(+)Gram(−)
S. aureus (ATCC 25923)S. epidermidis (NCTC 11047)B. cereus
(ATCC 14579)
E. coli
(NCTC 9001)
Salmonella
Enteritidis
(ATCC 13076)
P. aeruginosa
(ATCC 10145)
O. europaea Cobrançosa0013.16 ± 3.97 a,b011.57 ± 0.80 b13.04 ± 0.53 b
O. europaea Madural0010.67 ± 0.61 b013.54 ± 0.10 b11.44 ± 0.94 b
O. europaea Verdeal12.38 ± 0.60 a011.30 ± 0.70 b012.67 ± 0.62 b11.83 ± 1.01 b
Lactic acid15.69 ± 2.07 a22.24 ± 1.1918.42 ± 0.57 a17.67 ± 1.1118.97 ± 1.40 a19.74 ± 3.61 a
DMSO000000
Results are expressed as mean ± standard deviation of three determinations (n = 3). For each column, different superscript letters mean statistically significant differences at p < 0.05.
Table 7. IC50 values for AChE and BuChE inhibition by the O. europaea extracts from Cobrançosa, Madural, and Verdeal cultivars.
Table 7. IC50 values for AChE and BuChE inhibition by the O. europaea extracts from Cobrançosa, Madural, and Verdeal cultivars.
SampleAChE—IC50 (µg/mL)BuChE—IC50 (µg/mL)
O. europaea Cobrançosa995.51869.6
O. europaea Madural376.3>2000
(47.4% inhibition at 2000 µg/mL)
O. europaea Verdeal1057.91987.1
Table 8. IC50 values for the inhibition of MAO-A and MAO-B by the extracts of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal.
Table 8. IC50 values for the inhibition of MAO-A and MAO-B by the extracts of O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal.
SampleMAO-A—IC50 (µg/mL)MAO-B—IC50 (µg/mL)
O. europaea Cobrançosa251.1516.1
O. europaea Madural194.1>1000
(36.0% at 1000 µg/mL)
O. europaea Verdeal294.4792.1
Table 9. IC50 values for the inhibition of ACE and renin by leaf extracts from O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal.
Table 9. IC50 values for the inhibition of ACE and renin by leaf extracts from O. europaea Cobrançosa, O. europaea Madural, and O. europaea Verdeal.
SampleACE—IC50 (µg/mL)Renin—IC50 (µg/mL)
O. europaea Cobrançosa712.5<125.0
(66.4% inhibition at 125 µg/mL)
O. europaea Madural553.2<125.0
(69.80% inhibition at 125 µg/mL)
O. europaea Verdeal442.4<125.0
(68.01% inhibition at 125 µg/mL)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

de Oliveira, N.M.; Machado, J.; Chéu, M.H.; Lopes, L.; Barroso, M.F.; Silva, A.; Sousa, S.; Domingues, V.F.; Grosso, C. Potential Therapeutic Properties of Olea europaea Leaves from Selected Cultivars Based on Their Mineral and Organic Profiles. Pharmaceuticals 2024, 17, 274. https://doi.org/10.3390/ph17030274

AMA Style

de Oliveira NM, Machado J, Chéu MH, Lopes L, Barroso MF, Silva A, Sousa S, Domingues VF, Grosso C. Potential Therapeutic Properties of Olea europaea Leaves from Selected Cultivars Based on Their Mineral and Organic Profiles. Pharmaceuticals. 2024; 17(3):274. https://doi.org/10.3390/ph17030274

Chicago/Turabian Style

de Oliveira, Natália M., Jorge Machado, Maria Helena Chéu, Lara Lopes, M. Fátima Barroso, Aurora Silva, Sara Sousa, Valentina F. Domingues, and Clara Grosso. 2024. "Potential Therapeutic Properties of Olea europaea Leaves from Selected Cultivars Based on Their Mineral and Organic Profiles" Pharmaceuticals 17, no. 3: 274. https://doi.org/10.3390/ph17030274

APA Style

de Oliveira, N. M., Machado, J., Chéu, M. H., Lopes, L., Barroso, M. F., Silva, A., Sousa, S., Domingues, V. F., & Grosso, C. (2024). Potential Therapeutic Properties of Olea europaea Leaves from Selected Cultivars Based on Their Mineral and Organic Profiles. Pharmaceuticals, 17(3), 274. https://doi.org/10.3390/ph17030274

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop